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Sammendrag
Målet med denne oppgaven er å syntetisere et tokoferol/karotenoid-
derivat (1, figur I). Dette nye antioksidant-derivatet antas å utvise
synergisme mellom sine kromanol- og polyen-bestanddeler. Syntesen
av 1 ble fullført til og med den siste forløperen 12.
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Figur I: Syntese av 1.
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Kommersielt tilgjengelig Trolox (7) ble redusert med Red-Al® til
8 (trinn a) med 95% utbytte. Kromanol-aldehyd 9 ble dannet ved
Swern-oksidasjon av 8 med 65% utbytte (trinn b). En Wittig-reaksjon
mellom 9 og fosfoniumsalt 10 ga 11 med 33% utbytte og varierende
cis : trans-forhold (trinn c). Følgende forlengelse av polyenkjeden ga
12 (14% utbytte, trinn d). Wittig-reaksjonene ble gjennomført med
refluks og bestråling med mikrobølger.
Flere forsøk på å beskytte fenol-gruppen i intermediatet 8 ved
silylering eller benzylering førte kun til dannelse av 8B. Oksidasjon
av 8 ved Dess-Martin-oksidasjonen ga det uventede quinon-lignende
derivatet 27. Forsøk på å beskytte fenol-gruppen i intermediatet 9
ved benzoylering og silylering ga kun 9A, som er uløselig i alle vanlige
løsningsmidler.
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Abstract
The goal of this work is the synthesis of a tocopherol/carotenoid hy-
brid derivative (1, figure II). The novel derivative is believed to exhibit
synergistic antioxidant effects between its chromanol and polyene con-
situents. The synthesis of 1 was completed up to and including the
immediate precursor 12.
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Figure II: Synthesis of 1.
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Commercially avaliable Trolox (7) was reduced by Red-Al® to 8
(step a) in 95% yield. Chromanol aldehyde 9 was formed by Swern
oxidation of 8 in 65% yield (step b). Wittig reaction between 9 and
phosphonium salt 10 afforded 11 in 33% yield and varying cis : trans
ratio (step c), and subsequent elongation produced 12 (14% yield, step
d). The Wittig reactions were performed with reflux and microwave
irradiation.
Various attempts at protecting the phenolic group in intermedi-
ate 8 by silylation or benzylation did only lead to formation of 8B.
Oxidation of 8 by the Dess-Martin oxidation formed the unexpected
quinone-like derivative 27. Efforts to protect the phenolic group in in-
termediate 9 by benzoylation and silylation only produced 9A, found
to be unsoluble in all common laboratory solvents.
O
HO
O
8B
Si OO
O
27
O
O
OO
9A
vii
Contents
Acknowledgements iii
Sammendrag iv
Abstract vi
Table of Contents viii
List of Symbols and Abbreviations xiii
List of Figures xvi
List of Tables xix
1 Introduction 20
1.1 Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2 Theory 26
2.1 Carotenoids . . . . . . . . . . . . . . . . . . . . . . . . 26
2.1.1 Absorption and distribution . . . . . . . . . . . 28
2.1.2 Metabolism and bioactivity . . . . . . . . . . . 28
2.2 Vitamin E . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.2.1 Absorption, distribution and metabolism . . . 30
2.2.2 Bioactivity . . . . . . . . . . . . . . . . . . . . 30
2.3 Antioxidants . . . . . . . . . . . . . . . . . . . . . . . 31
2.3.1 Antioxidative properties of carotenoids . . . . . 31
2.3.2 Antioxidative properties of α-tocopherol . . . . 33
viii
2.3.3 Synergism between antioxidants . . . . . . . . 34
2.4 Transfection vectors in gene therapy . . . . . . . . . . 38
2.4.1 Classes of gene transfection vectors . . . . . . . 39
2.4.2 Nucleic acid delivery via lipoplexes . . . . . . . 39
2.5 Microwave technology in organic synthesis . . . . . . . 40
2.6 Reaction theory and mechanisms . . . . . . . . . . . . 42
2.6.1 Carbonyl reduction by hydride-donor reagents 42
2.6.2 The Swern oxidation . . . . . . . . . . . . . . 43
2.6.3 The Dess-Martin oxidation . . . . . . . . . . . 45
2.6.4 The Wittig reaction . . . . . . . . . . . . . . . 46
2.6.5 Hydrolysis of acetals . . . . . . . . . . . . . . . 48
2.6.6 Benzoyl protection and deprotection . . . . . . 49
2.6.7 Silyl protection and deprotection . . . . . . . . 49
2.6.8 Benzyl protection and deprotection . . . . . . . 50
3 Results and Discussion 52
3.1 Synthesis of 8 . . . . . . . . . . . . . . . . . . . . . . . 52
3.2 Synthesis of 9 . . . . . . . . . . . . . . . . . . . . . . . 55
3.2.1 The Swern oxidation . . . . . . . . . . . . . . 56
3.2.2 Silyl ether protection and deprotection . . . . 58
3.2.3 Benzyl ether protection and deprotection . . . 60
3.2.4 The Dess-Martin oxidation . . . . . . . . . . . 61
3.3 Synthesis of 11 . . . . . . . . . . . . . . . . . . . . . . 63
3.4 Synthesis of 12 . . . . . . . . . . . . . . . . . . . . . . 66
3.5 Protection of 9 . . . . . . . . . . . . . . . . . . . . . . 69
3.5.1 Protection by benzoylation . . . . . . . . . . . 69
3.5.2 Attempted protection by silylation . . . . . . . 71
3.6 Future work . . . . . . . . . . . . . . . . . . . . . . . . 71
4 Conclusion 73
5 Spectroscopy 76
5.1 Compound 8 . . . . . . . . . . . . . . . . . . . . . . . 76
5.1.1 NMR spectroscopy . . . . . . . . . . . . . . . . 76
5.1.2 MS fragmentation . . . . . . . . . . . . . . . . 77
5.2 Compound 8B . . . . . . . . . . . . . . . . . . . . . . 79
5.3 Compound 27 . . . . . . . . . . . . . . . . . . . . . . . 80
ix
5.3.1 NMR spectroscopy . . . . . . . . . . . . . . . . 80
5.3.2 MS fragmentation . . . . . . . . . . . . . . . . 81
5.4 Compound 9 . . . . . . . . . . . . . . . . . . . . . . . 83
5.4.1 NMR spectroscopy . . . . . . . . . . . . . . . . 83
5.4.2 MS fragmentation . . . . . . . . . . . . . . . . 84
5.5 Compound 11 . . . . . . . . . . . . . . . . . . . . . . . 85
5.5.1 NMR spectroscopy . . . . . . . . . . . . . . . . 86
5.5.2 MS fragmentation . . . . . . . . . . . . . . . . 89
5.6 Compound 12 . . . . . . . . . . . . . . . . . . . . . . . 90
5.6.1 NMR spectroscopy . . . . . . . . . . . . . . . . 91
5.6.2 MS fragmentation . . . . . . . . . . . . . . . . 93
5.7 Compound 9A . . . . . . . . . . . . . . . . . . . . . . 94
6 Experimental 96
6.1 General methods . . . . . . . . . . . . . . . . . . . . . 96
6.1.1 Chemicals and solvents . . . . . . . . . . . . . 96
6.1.2 Chromatographic techniques . . . . . . . . . . 96
6.1.3 Spectroscopic analyses . . . . . . . . . . . . . . 97
6.2 Synthesis of 8 . . . . . . . . . . . . . . . . . . . . . . . 98
6.3 Attempted protection of 8 . . . . . . . . . . . . . . . . 99
6.3.1 Protection by silylation . . . . . . . . . . . . . 99
6.3.2 Attempted recovery of 8 from 8B . . . . . . . 100
6.3.3 Protection by benzylation . . . . . . . . . . . . 100
6.4 Synthesis of 9 . . . . . . . . . . . . . . . . . . . . . . . 101
6.4.1 Attempted synthesis by the Dess-Martin
oxidation . . . . . . . . . . . . . . . . . . . . . 101
6.4.2 Synthesis by the Swern oxidation . . . . . . . . 102
6.5 Synthesis of 11 . . . . . . . . . . . . . . . . . . . . . . 104
6.5.1 Method 1: Epoxide mediation under microwave
conditions . . . . . . . . . . . . . . . . . . . . . 104
6.5.2 Method 2: Epoxide mediation under reflux . . 104
6.5.3 Method 3: Base mediation under microwave
conditions . . . . . . . . . . . . . . . . . . . . . 105
6.5.4 Method 4: Base mediation under reflux . . . . 106
6.5.5 Alternative method of hydrolyzing the acetal
precursor to 11 . . . . . . . . . . . . . . . . . . 107
x
6.6 Synthesis of 12 . . . . . . . . . . . . . . . . . . . . . . 108
6.7 Attempted protection of 9 . . . . . . . . . . . . . . . . 109
6.7.1 Protection by benzoylation . . . . . . . . . . . 109
6.7.2 Protection by silylation . . . . . . . . . . . . . 111
References 112
Appendixes 119
A Spectroscopic data of 8 . . . . . . . . . . . . . . . . . 121
B Spectroscopic data of 8B . . . . . . . . . . . . . . . . 129
C Spectroscopic data of 27 . . . . . . . . . . . . . . . . . 131
D Spectroscopic data of 9 . . . . . . . . . . . . . . . . . 140
E Spectroscopic data of 11 . . . . . . . . . . . . . . . . . 148
F Spectroscopic data of 12 . . . . . . . . . . . . . . . . . 167
G Spectroscopic data of 9A . . . . . . . . . . . . . . . . 178
xi
xii
List of Symbols and
Abbreviations
2D Two-dimensional
A The pre-exponential constant in the Arrhenius equation
Ac Acetyl, CH3CO
BHT Butylated hydroxytoluene, 2,6-di-tert-butyl-4-methylphenol
Bn Benzyl
Bz Benzoyl
c The speed of light in vacuum, 299,792,458 m/s.1
COSY (H,H)-correlated spectroscopy
DCC N,N ′-Dicyclohexylcarbodiimide
DEPT Distortionless enhancement polarization transfer spectr.
DMAP 4-(Dimethylamino)pyridine
DMF N,N -Dimethylformamide
DMSO Dimethyl sulfoxide
E Energy
Ea Activation energy
xiii
eq Equivalents (by mol)
Et Ethyl, CH3CH2
EtOH Ethanol, CH3CH2OH
eV Electron volt
h Planck’s constant, 6.62606896× 10−34 J s.1
HDL High-density lipoproteins
HMBC Heteronuclear multiple bond correlation spectroscopy
HPLC High-performance liquid chromatography
HRMS High resolution mass spectrometry
HSQC Heteronuclear single quantum coherence spectroscopy
IR Infrared spectroscopy
k The rate constant of a chemical reaction
λ Wavelength
λmax Wavelength of maximum absorption
LDL Low-density lipoproteins
LRMS Low resolution mass spectrometry
Me Methyl, CH3
MeOH Methanol, CH3OH
MS Mass spectrometry
MW Microwave
NMR Nuclear magnetic resonance spectroscopy
Ph Phenyl, C6H5
xiv
R The Universal gas constant, 8.3144621 J mol-1 K-1.1
ROS Reactive oxygen species
RT Room temperature
siRNA Small interfering ribonucleic acid
T Temperature
TBAF Tetrabutylammonium fluoride
TBDMS tert-Butyldimethylsilyl
THF Tetrahydrofuran
TLC Thin layer chromatography
p-TsOH p-Toluenesulfonic acid
UV/Vis Ultraviolet-visible spectroscopy
VLDL Very low-density lipoproteins
xv
List of Figures
1.1 1 combines structural elements from the natural
antioxidants α-tocopherol (2) and β-carotene (3). . . . 21
1.2 Gene transfection agents based on carotenoids (4),
α-tocopherol (5) and target molecule 1 (6). . . . . . . 22
1.3 The structures of Trolox (7), chromanol aldehyde 9,
FeAox-6 and α-T6. . . . . . . . . . . . . . . . . . . . . 23
1.4 The synthesis of 1. . . . . . . . . . . . . . . . . . . . . 25
2.1 Structures of selected example carotenoids and apo-
carotenoids. . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2 Structures of vitamin E tocopherols and tocotrienols. . 29
2.3 Generation of 1O2 and ROS, and prevention of oxida-
tive degeneration of biological material by carotenoid
and vitamin E antioxidants. . . . . . . . . . . . . . . . 32
2.4 Mechanism for the radical scavenging activity of β-
carotene. . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.5 Mechanism for the radical scavenging activity of α-
tocopherol and the fate of the resulting radical. . . . . 34
2.6 Structures of novel chemical combinations of anti-
oxidants. . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.7 Chain phosphate linkers give RNA and DNA net neg-
ative charge. . . . . . . . . . . . . . . . . . . . . . . . . 38
2.8 The structures of DiBAlH (23) and Red-Al® (24). . . 42
2.9 Reaction mechanism for reduction of an acid by a lithium
aluminium hydride reagent. . . . . . . . . . . . . . . . 43
2.10 The mechanism of the Swern oxidation. . . . . . . . . 44
xvi
2.11 A common side reaction to the Swern oxidation, form-
ing thioacetal byproducts. . . . . . . . . . . . . . . . . 44
2.12 The mechanism of the Dess-Martin oxidation. . . . . . 45
2.13 Hydrolysis of 25 generates the more active reagent 26. 45
2.14 The general mechanism for the Wittig reaction with an
aldehyde. . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.15 Epoxide mediated ylide formation. . . . . . . . . . . . 47
2.16 Kinetic (transition state) control of stereoselectivity in
the Wittig reaction. . . . . . . . . . . . . . . . . . . . 48
2.17 General mechanism for acid catalyzed hydrolysis of an
acetal. . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
2.18 Mechanism for benzoylation of a general alcohol with
pyridine catalysis. . . . . . . . . . . . . . . . . . . . . 49
2.19 Mechanism for silylation of a general alcohol with imi-
dazol catalysis. . . . . . . . . . . . . . . . . . . . . . . 50
2.20 Mechanism for the Williamson synthesis of benzyl
ethers. . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.1 Synthesis of 8. . . . . . . . . . . . . . . . . . . . . . . 52
3.2 Alternative strategies to 9. . . . . . . . . . . . . . . . 55
3.3 Synthesis of 9. . . . . . . . . . . . . . . . . . . . . . . 56
3.4 Synthesis of 8A. . . . . . . . . . . . . . . . . . . . . . 58
3.5 Deprotection of 8B. . . . . . . . . . . . . . . . . . . . 59
3.6 Synthesis of 8C. . . . . . . . . . . . . . . . . . . . . . 60
3.7 Selective solvation and complexation of K+ by 18-crown-
6 in acetone. . . . . . . . . . . . . . . . . . . . . . . . 60
3.8 Mechanism for catalysis of the formation of 8C by KI. 61
3.9 Attempted Dess-Martin oxidation of 8. 27 was formed
in favour of expected 9. . . . . . . . . . . . . . . . . . 61
3.10 Oxidation of α-tocopherol (2) to “α-tocopheroxide”. . 62
3.11 Tentative mechanism for the formation of 27 from 8. . 63
3.12 Synthesis of 11. . . . . . . . . . . . . . . . . . . . . . . 65
3.13 Synthesis of 12. . . . . . . . . . . . . . . . . . . . . . . 67
3.14 Photoinduced isomerization of 1 by I2. . . . . . . . . . 68
3.15 Synthesis of 9A. . . . . . . . . . . . . . . . . . . . . . 69
3.16 A general mechanism for the Steglich esterification. . . 70
3.17 Synthesis of 9B. . . . . . . . . . . . . . . . . . . . . . 71
xvii
3.18 A suggested analogue library for future structure-activity
relationship studies. . . . . . . . . . . . . . . . . . . . 72
5.1 Structure and numbering of atoms in 8. . . . . . . . . 76
5.2 Possible radical ion fragments of 8. . . . . . . . . . . . 78
5.3 Structure and numbering of atoms in 8B. . . . . . . . 79
5.4 Structure and numbering of atoms in 27. . . . . . . . 80
5.5 Possible radical ion fragments of 27. . . . . . . . . . . 82
5.6 Structure and numbering of atoms in 9. . . . . . . . . 83
5.7 Possible radical ion fragments of 9. . . . . . . . . . . . 85
5.8 Structure and numbering of atoms in (4Z )-11. . . . . 86
5.9 Structure and numbering of atoms in (4E)-11. . . . . 88
5.10 Structure and numbering of atoms in 12. . . . . . . . 91
5.11 Structure of 9A. . . . . . . . . . . . . . . . . . . . . . 94
5.12 Possible radical ion fragments of 9A. . . . . . . . . . . 95
xviii
List of Tables
3.1 Yields and conditions for the synthesis of 8. . . . . . . 53
3.2 Yields and conditions for the synthesis of 9. . . . . . . 57
3.3 Yields and conditions for the synthesis of 27. . . . . . 62
3.4 Yields and conditions for the synthesis of 11. . . . . . 64
3.5 Yields and conditions for the synthesis of 12. . . . . . 68
3.6 Yields and conditions for the synthesis of 9A. . . . . . 69
5.1 Assigned shifts for 8. . . . . . . . . . . . . . . . . . . . 77
5.2 Main MS fragments of 8. . . . . . . . . . . . . . . . . 78
5.3 Assigned shifts for 8B. . . . . . . . . . . . . . . . . . . 79
5.4 Assigned shifts for 27. . . . . . . . . . . . . . . . . . . 81
5.5 Main MS fragments of 27. . . . . . . . . . . . . . . . . 82
5.6 Assigned shifts for 9. . . . . . . . . . . . . . . . . . . . 83
5.7 Main MS fragments of 9. . . . . . . . . . . . . . . . . 84
5.8 Assigned shifts for (4Z )-11. . . . . . . . . . . . . . . . 87
5.9 Assigned shifts for (4E)-11. . . . . . . . . . . . . . . . 89
5.10 Main MS fragments of 11. . . . . . . . . . . . . . . . . 90
5.11 Assigned shifts for 12. . . . . . . . . . . . . . . . . . . 92
5.12 Main MS fragments of 12. . . . . . . . . . . . . . . . . 93
5.13 Main MS fragments of 9A. . . . . . . . . . . . . . . . 94
xix
Chapter 1
Introduction
Numerous attempts have previously been made at the synthesis of a
polyunsaturated analogue of vitamin E (α-tocopherol).2–4 By replac-
ing the saturated alkyl moiety of α-tocopherol with a fully unsatu-
rated polyene, one hopes to increase the antioxidant activity of the
molecule. Though some authors do not agree,5,6 most experiments
show that mixtures of antioxidants like α-tocopherol and carotenoids
(e.g. β-carotene) show a synergistic increase in antioxidant activ-
ity.7–13 Synergism means that the total antioxidant activity of the
mixture is greater than the sum of the contributions from each com-
ponent. Chemically combining the key structural elements of different
antioxidants in one molecule has also been reported to increase an-
tioxidant activity.14,15 Tocopherols, carotenoids and their antioxidant
activity are discussed more thoroughly in the following chapter.
This synergism is the origin of the interest in a fully unsaturated
analogue of α-tocopherol. The polyene chain intended to replace
the alkyl chain of α-tocopherol is also the key structural element of
carotenoids. It is thought to be responsible for the antioxidant prop-
erties of carotenoids. Taking this one step further, it would also be
interesting to investigate the antioxidant properties of a compound
combining full structural elements of carotenoids and α-tocopherol.
One example of such a compound is 1, the target molecule of this
work. Its structure is shown in figure 1.1. 1 combines structural
elements from α-tocopherol (2) and β-carotene (3).
20
OHO
O
HO
1
2
3
Figure 1.1: 1 combines structural elements from the natural antioxidants
α-tocopherol (2) and β-carotene (3).
Other compounds combining α-tocopherol and carotenoids have
been synthesized previously.2,16,17 These are based on ester and ether
linkages of carotenoic acids or alcohols and the chromanol acid Trolox
(7, figure 1.3), with or without a glycerol linker and additional an-
tioxidant moieties. However, the resulting compounds, though some
have not been tested, have proven to have at best additive antioxi-
dant effects. Even if no synergism is observed, these compounds still
advantageously provide the body with several different antioxidants
as post-absorptive metabolism may cleave the derivatives into their
constituents. Thus the body is provided with several antioxidants by
the absorption of a single molecule.16 By designing target molecule 1,
the polyene chain and the chromanyl system are brought into closer
proximity. This will hopefully intensify the synergistic interactions
between the two systems. Additionally, the phenolic hydrogen, in-
strumental to the antioxidant activity of the chromanol moiety, is left
unesterified.
In gene therapy, the delivery of new genetic material into the
21
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Figure 1.2: Gene transfection agents based on carotenoids (4), α-toco-
pherol (5) and target molecule 1 (6).
target cells depends on an efficient delivery system. Recently, a new
class of vectors suitable for siRNA delivery based on carotenoids was
reported.18,19 An example of such a compound (4) is shown in figure
1.2. These novel, single-chain rigid cationic carotenoid lipids show
promising delivery efficiency, among with low cytotoxic side effects.
Tocopherols have also recently been derivatized into cationic lipids
like 5 suitable for application as gene vectors.20 Similarly, 1 may
be derivatized into a cationic lipid (6). This derivative may repre-
sent another novel class of gene transfer molecules, unifying the novel
carotenoid and tocopherol cationic lipids.
1.1 Strategy
Several strategies have been employed in the pursuit of an unsaturated
α-tocopherol analogue. Størseth2 attempted to directly couple an
apocarotenoid based Wittig salt with an aldehydic derivative 9 (figure
22
1.1. Strategy
O
HO
O
HO
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O
HO
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HO H
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FeAox-6
α-T6
Figure 1.3: The structures of Trolox (7), chromanol aldehyde 9, FeAox-63
and α-T6.4
1.3) of the chromanol ring system of α-tocopherol, and vice versa.
These attempts failed.
Palozza et al.3 successfully coupled a shorter polyene Wittig salt
with the same chromanol aldehyde 9, though without full conjugation
of the polyene moiety. This unsaturated α-tocopherol analogue called
FeAox-6 also lacks the functionality for further elongation.
Atkinson et al.4 succeeded in producing an unsaturated α-toco-
pherol analogue in 2010, the year this work was commenced. Their
strategy was to couple the chromanol aldehyde 9 with a Wittig salt
containing additional functionality, allowing subsequent elongation to
form a polyenic tocopherol analogue α-T6. The synthesis of α-T6
involves an intermediate common to the strategy employed in this
work.
The synthesis of tocopherol-carotenoid 1 was based on coupling
chromanol aldehyde 9 with Wittig salt 10 containing a short polyene
chain and a protected aldehyde functionality. After deprotection,
corresponding Wittig elongation of the polyene chain and coupling
23
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with Wittig salt 13 should lead to 1. This is summarized in figure
1.4.
The use of protection groups when working with carotenoids is
complicated by the sensitivity of these compounds. Many deprotec-
tion methods would decompose the target 1. With step economy also
taken into consideration, the Wittig reaction was performed without
protection of the phenol group. A similar step without protection
was employed by Palozza et al.3 in their synthesis of FeAox-6. Nev-
ertheless, the Wittig reaction could also be attempted with benzoyl
protection of the phenol group. A mild reductive deprotection of this
group has been reported to leave the polyene chain intact.26
24
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Figure 1.4: The synthesis of 1. (a) NaAlH2(OCH2CH2OCH3)2, THF,
0 ◦C.2 (b) DMSO, (COCl)2, NEt3, CH2Cl2, -78 ◦C.21 (c)
1. CH3OK, CH3OH, CH2Cl2, MW. 2. p-TsOH, CH2Cl2, 30
min.22,23 (d) 1. CH3OK, CH3OH, CH2Cl2, reflux. 2. p-TsOH,
CH2Cl2, 30 min.22,23 (e) 1. EtOH, 1,2-epoxybutane, MW. 2.
p-TsOH, CH2Cl2, 30 min.24 (f) 1. EtOH, 1,2-epoxybutane,
reflux. 2. p-TsOH, CH2Cl2, 30 min.24 (g) BzCl, pyridine,
CH2Cl2.25 (h) DiBAlH, CH2Cl2.26
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Chapter 2
Theory
This chapter will give a general survey of the theoretical background of
this work. This includes some background information on carotenoids
and tocopherols, and a general introduction to antioxidants and the
antioxidative properties of carotenoids and tocopherols. Gene trans-
fection vectors will also be discussed briefly. The final sections will
discuss the use of microwave technology in organic synthesis, and con-
sider reaction theory and mechanisms in somewhat more detail.
2.1 Carotenoids27,28a
Carotenoids are naturally occuring pigments and antioxidants dis-
tributed widely throughout Nature. Structurally they are classified
as terpenoids, composed of several isoprene units. Carotenoids are
distinguished by a long, conjugated polyene system, acting as a chro-
mophore. This gives carotenoids bright colours, typically in the orange
to red part of the spectrum. In their naturally occuring environment
carotenoids are quite stable, but when isolated they become sensi-
tive to light, heat and oxygen. Their limited solubility in common
laboratory solvents is another challenge in carotenoid chemistry.
Carotenoids constitute a large and varied class of natural products.
They occur as hydrocarbons, or xanthophylls containing function-
alized carotenoids with hydroxy, carbonyl, ether and epoxy groups.
Some examples of carotenoids are given in figure 2.1. The Greek let-
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Figure 2.1: Structures of selected example carotenoids and apocarotenoids.
ter suffix specifies the structure of the cyclohexene moieties, thus 3
is β, β′-carotene. The acyclic lycopene (14) carotene may be formally
derived into all other tetraterpenoid (C40) carotenoids by modification
or cyclization of one or both ends of the chain. It is found in red toma-
toes, as well as in many kinds of fruit and berries. Zeaxanthin (15) is a
common pigment in algae and plants, while astaxanthin (16) accounts
27
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for red colours in many animals, e.g. salmon and crustaceans.
2.1.1 Absorption and distribution
The oral bioavailability of carotenoids is typically in the range of 10–
30%.29 Absorption is complex and among other factors depends on the
geometry of the double bonds, the hydrophilicity of the carotenoid and
co-formulation with dietary lipids. In general, increased hydrophilicity
of the carotenoid increases bioavailability. All-trans isomers may have
higher bioavailability than cis isomers, but this conclusion is under
debate.28b Intestinal uptake of carotenoids is aided by formation of
bile acid lipid micelles, and increased lipid content of the diet is seen
to increase the uptake of carotenoids.
Transportation of carotenoids in the blood is performed by lipopro-
teins. Carotenes are mainly transported in low-density lipoproteines
(LDL), while more polar carotenoids are transported in high-density
lipoproteins (HDL). Adipose tissue is the main storage site for caroten-
oids, though high concentrations are also found in hepatic, adrenal
and reproductive tissues. High concentrations of carotenoids and apo-
carotenoids are also found in the retina, as they have an important
function in the mechanics of vision (see section 2.1.2).
2.1.2 Metabolism and bioactivity
Apocarotenoids are formed by oxidative cleavage of carotenoids, and
frequently contain functionalities like hydroxy, aldehyde, carboxyl and
ester groups. One important group of apocarotenoids are the vita-
min A retinoids. Retinol (17, figure 2.1), is formed in mammals via
the corresponding aldehyde retinal (β-apo-15-carotenal) by enzymatic
cleavage with βcarotene 15,15 ′-dioxygenase. Notably, α-tocopherol
is required in this biotransformation.30 Carotenoids containing at
least one β-ionone ring (like β-carotene) are considered pro-vitamin
A compounds. Other apocarotenoids may also be formed by similar
oxidative degradation. The vitamin A retinoids are instrumental to
scoptic and colour vision. The oxidized form retinoic acid also finds
importance as a hormon-like growth factor for epithelial cells.31
The conjugated polyene chain also imposes antioxidant properties
28
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on carotenoids. These are treated in section 2.3.1. In combination
with the presence of carotenoids in key tissues, potential beneficial
health effects and disease prevention has been suggested from a diet
high in carotenoids. These include protection against cancer, eye dis-
eases, UV-induced skin damage, cardiovascular disease and enhance-
ment of immune system function. Some of these effects may be at-
tributed to the antioxidant properties of carotenoids, while others may
be caused by regulatory effects on gene expression.
2.2 Vitamin E28c,32a
Vitamin E is a group of eight compounds, all exhibiting the same
activity to larger or lesser extent. They all feature a chroman ring
system with a phenol functionality and various degrees of aromatic
ring substitution. Position 2 is also substituted with a long alkyl
chain, either saturated or partly unsaturated. The compounds can be
divided into two classes according to saturation: Tocopherols have a
saturated hydrocarbon phytyl tail, while tocotrienols have three dou-
ble bonds in the chain. The structures of tocopherols and tocotrienols
are shown in figure 2.2.
O
∗
R3
R2
HO
R1
∗ ∗
α − R1 = R2 = R3 = CH3
β − R2 = H, R1 = R3 = CH3
γ − R1 = H, R2 = R3 = CH3
δ − R1 = R2 = H, R3 =  CH3
O
∗
R3
R2
HO
R1
Tocopherol
Tocotrienol
1 2
3
45
6
7
8
1 2
3
45
6
7
8
Figure 2.2: Structures of vitamin E tocopherols and tocotrienols.
29
CHAPTER 2: Theory
Note that tocopherols have three stereogenic centers, while to-
cotrienols have only one. All natural forms of vitamin E have 2R
configuration, which is required for vitamin activity. Activities dif-
fer according to configurations and substitution pattern. (R,R,R)-α-
Tocopherol has the highest vitamin E activity, and the highest natu-
ral abundance. The chromanol head moiety is the active part of the
molecule; compounds without the hydrocarbon tail also exhibit ac-
tivity. A previously mentioned example is Trolox (7). The function
of the hydrocarbon tail is to increase the lipophilicity of the vitamin,
allowing incorporation into biological lipid membranes.
2.2.1 Absorption, distribution and metabolism
Plant seed oils are rich in Vitamin E, which is normally supplied
through the diet. Similar to carotenoids, the absorption of vitamin E
depends on the formation of lipid micelles aided by bile acid salts. The
bioavailability of α-tocopherol is typically around 15–45%. Esterase
and lipase enzymes from the pancreas hydrolyze common esters of
tocopherols and tocotrienols into their active form. The vitamin is
transported to the liver via lipids and carotenoids in chylomicrons.
The liver preferentially secretes the most active (R,R,R)-α-toco-
pherol in very low-density lipoproteins (VLDL) for redistribution to
VDL and HDL, and further distribution to tissues. Targets for dis-
tribution include erythrocytes and adipose, hepatic, brain and muscle
tissues.
2.2.2 Bioactivity
Vitamin E is a powerful antioxidant, of which α-tocopherol is the most
potent form. This is discussed more thoroughly in section 2.3.2. α-
Tocopherol is the major chain-breaking antioxidant in the body, and
protects against major degenerative diseases in which free radicals are
implied. Examples are cancer, cardiovascular disease, and pollution
damage. Vitamin E has also been suggested to protect against aging
processes and free-radical mediated tissue damage during exercise.
In addition to its antioxidant activity, vitamin E has important
regulatory responsibilities in prostaglandin synthesis, protein kinase
30
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C activation, mitochondrial function and the metabolism of proteins
and nucleic acids.
2.3 Antioxidants28d
Antioxidants have the ability to prevent the oxidation of other com-
pounds. In a biological context, an antioxidant inhibits the oxida-
tive degeneration of biological material by free radical reactive oxy-
gen species (ROS). ROS are generated by singlet oxygen (1O2), a
highly reactive, non-radical form of molecular oxygen formed by ra-
diative exitation. As the relaxation of the singlet to the triplet state
(1∆g → 3Σ−g ) is strictly forbidden by spin and parity, the 1O2 species
is relatively long-lived. 1O2 in turn forms the highly toxic superoxide
radical (O2•−), subsequently forming the hydroxyl radical (HO•) and
a wide variety of peroxyl and alkoxyl radicals (ROO• and RO•).
In vivo, ROS are generated as a byproduct from the electron trans-
port chain in mitochondrial respiration.33a If no measures are taken,
ROS initiates chain radical reactions destroying cellular material like
lipids, proteins and genetic material. To prevent this, the body relies
on the presence of antioxidants to quench 1O2 physically or scavenge
radical species chemically. Antioxidants are assisted by enzymes such
as superoxide dismutase If the generation of ROS exceeds the capacity
of antioxidant protection, or if the ability of antioxidants to counter-
act ROS is compromised, the resulting physiological condition is called
oxidative stress.
The generation and consequences of 1O2 and ROS, and the pre-
ventive effect of antioxidants such as carotenoids and vitamin E, are
illustrated in figure 2.3. The mechanism of action of carotenoids and
vitamin E will be detailed in the following sections.
2.3.1 Antioxidative properties of carotenoids28e
As briefly mentioned in section 2.1.2, carotenoids are antioxidants.
This property is explained in terms of the conjugated system common
to all carotenoids. Carotenoids may act as antioxidants by several
mechanisms. The major mode of action (shown in figure 2.3) is by
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O2 1O2
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HOO , HO , ROO , RO
O2
Biological material
Radical decomposition
products
Oxidized biological
material
Oxidized biological
material
Biological material
Radical chain
reaction
Carotenoids quench
singlet oxygen
Vitamin E scavenges radicals
pre-chain reaction
Vitamin E quenches radicals,
terminating the chain reaction
Figure 2.3: Generation of 1O2 and ROS, and prevention of oxidative de-
generation of biological material by carotenoid and vitamin E
antioxidants.
physical quenching of 1O2, as illustrated in equations 2.1 and 2.2.
The high energy of 1O2 is transferred to the carotenoid [Car], forming
ground state 3O2 and triplet carotenoid 3[Car]∗, which is relaxed to the
ground state by dissipation of thermal energy. This process is expected
to proceed through rotational and vibrational energy levels.34
1O2 + [Car]→3O2 +3 [Car]∗ (2.1)
3[Car]∗ → [Car] + thermal energy (2.2)
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The carotenoid is not decomposed in this process, so one carotenoid
molecule may quench many 1O2 before being metabolized. Chemical
quenching, a minor antioxidant mechanism, destroys the carotenoid.35
Carotenoids are also radical scavengers and so may also exert an
inhibitory antioxidative effect at all indicated steps in figure 2.3. This
mechanism however contributes only minutely to the total antioxidant
action of carotenoids. An example of the radical scavenging activity of
β-carotene is shown in figure 2.4. The peroxide radical ROO• forms
a radical adduct with β-carotene. The radical is stabilized through
extensive conjugation throughout the polyene system.
ROO
OOR
Figure 2.4: Mechanism for the radical scavenging activity of β-carotene.
2.3.2 Antioxidative properties of α-tocopherol28c
In section 2.2.2, vitamin E and in particular (R,R,R)-α-tocopherol
was mentioned as a very potent radical scavenging antioxidant, and
the most important lipid soluble antioxidant in the human body. It
protects important unsaturated fatty acids in cell membranes.
The phenol group is instrumental to the activiy of α-tocopherol.
Radical scavenging occurs via abstraction of the phenolic proton and
formation of a resonance stabilized radical. The vitamin E radical
may either form stable dimers, stable adducts with other radicals, or
proceed through other radical reactions (figure 2.5).
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Figure 2.5: Mechanism for the radical scavenging activity of α-tocopherol
and the fate of the resulting radical.
2.3.3 Synergism between antioxidants
Young et al.36 have suggested that alterations in antioxidative proper-
ties may be observed if two antioxidants are in continguity. There are
four potential outcomes of such an alteration of activity. If there is
no unexpected alteration, antioxidant activities are additive, meaning
the antioxidant activity of the system equals the sum of the individual
activities of the constituent compounds. Alternatively one may ob-
serve a synergistic effect, where the total antioxidant activity equals
more than the sum of the constituent compound activities. Finally,
the outcome may be antagonism, in which the total activity is less
34
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than the sum of the activity of the contributing compounds.
There are generally two possibilities for combining antioxidants.
The first one is physical combination, i.e. mixtures of distinct com-
pounds. The other method is chemical combination of two antioxidant
moieties in the same molecule. This latter method has the additional
advantage of allowing the uptake of several antioxidants through only
one absorption and subsequent metabolic cleavage. Størseth made a
survey of the effects of physical and chemical combinations of antioxi-
dants in 2001.2 This review forms the base of the following discussion
of physical and chemical antioxidant combinations, with some addi-
tional newer references and updates.
Physical combination of antioxidants
As reported by Størseth,2 there have been varying reports of synergism
and antagonism in physical mixtures of antioxidants. Synergism is
found in various binary and tertiary mixtures of assorted antioxidants
like vitamin E (α-tocopherol), β-carotene, ascorbic acid (vitamin C),
the flavonoid rutin, a selenaalkylglyceryl ether, and β-apo-8′-caroten-
oic acid esters.7,8, 11–13,37,38 However, there are also reports of an
additive effect (α-tocopherol and rutin).38
The effects excerted between α-tocopherol and carotenoids are un-
der particular controversy. Many studies9,10,12,13,37 find there is a
synergistic effect while others5,6 find no effect or even antagonism.
Chemical combination of antioxidants
Chemically combining the key structural elements of different antioxi-
dants (carotenoids, selenium, sulfur, α-tocopherol, Trolox (7), vitamin
C) in one molecule has also been reported to increase antioxidant ac-
tivity by synergism.39,40 Other results include antagonism41,42 and
additive effects.17,40 The activities of several combination antioxi-
dants have not been measured.16,43
The novel trolox-carotenoid and BHT-carotenoid combinations (18
and 19, respectively) synthesized by Størseth2,44 are shown in figure
2.6. 19 proved to be unstable and with no antioxidant properties,
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while 18 was shown to have a concentration dependant antioxidant
activity comparable to a mixture of α-tocopherol and β-carotene.44
Palozza et al.3 reported in 2002 the synthesis of a partly unsat-
urated α-tocopherol antioxidant named FeAox-6 (figure 2.6). It was
later shown to have an antioxidant activity greater than that of the
tocotrienols.14 The authors propose that the conjugated double bonds
contribute to increased antioxidant activity by four mechanisms. Re-
duced flexibility leads to a more ordered distribution of FeAox-6 in a
membrane bilayer. Enhancement of the interaction of chromanyl ring
with radicals and possibility to trap radicals in the chromanyl ring
and polyene also contribute. The final mechanism is suggested to be
increased efficiency of chromanyl regeneration.
A novel class of combination antioxidants, carotenylflavonoids,
were synthesized in 2007.45 The class combines carotenoids with flavo-
noids, a class of natural compounds with a central tricyclic unsatu-
rated system with inherent antioxidative properties. Compound 20
in figure 2.6 is an example of this class. Carotenylflavonoids show
synergism in their antioxidant properties.
Atkinson et al.4 synthesized a fully unsaturated α-tocopherol ana-
logue α-T6 in 2010. Its structure is shown in figure 2.6. The an-
tioxidant activity of α-T6 was not measured quantitatively, but it
was shown by decay of fluorescence that the derivative is sensitive
to peroxidative degradation, i.e. the polyene chain has antioxidant
properties.
Assorted varieties of carotenoid retinoate esters were recently re-
ported for the first time.46 These compounds contain two or even three
separate polyene chains. The group includes retinoate esters and di-
esters of sec allylic and non-allylic carotenols. A general structure of
a carotenoid retinoate 21 is shown in figure 2.6. [Car] represents any
carotenol moiety. The antioxidant activities of these compounds were
not reported.
The synthesis of a series of novel phenolic antioxidants was recently
described.15 These antioxidants combine the chromanol moiety of vi-
tamin E with catechol moieties to form very potent radical scavengers.
An example is 22 in figure 2.6.
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Figure 2.6: Structures of novel chemical combinations of antioxidants.
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2.4 Transfection vectors in gene therapy18,47,48
Gene therapy aims to treat diseases at the genetic level by introduc-
tion of new genetic material into the cells. The introduced genetic
material is typically DNA (to replace defective genes) or small in-
terfering RNA (siRNA) designed to downregulate or silence overex-
pressed target genes. Because gene therapy does not simply relieve
the symptoms, but rather alleviate the fundamental cause of disease,
it has potential to cure serious illnesses previously considered difficult
or impossible to treat. Examples of such diseases are severe combined
immunodeficiency disease (SCID)49 and Duchenne muscular dystro-
phy.19,50
Nucleic acid segments are quite polar and therefore unable to cross
the lipid double layer constituting the cellular membrane. Addition-
ally, nucleic acid strands have a net negative charge because of the
phosphate groups in the strand backbone, as shown in figure 2.7. This
means that passive diffusion of nucleic acids into cells would have to
go against the voltage gradient of the transmembrane potential.33b
Hence, the introduction of new genetic material requires facilitation.
Currently, the most used methods rely on delivery by a vector, i.e. a
transportation vehicle for the genetic material.
O
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Figure 2.7: Chain phosphate linkers give RNA (R = OH) and DNA
(R = H) net negative charge.
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2.4.1 Classes of gene transfection vectors
Contrary to direct physical delivery techniques (e.g. microinjection
and bioballistics), the use of vector delivery shows promise for clinical
utilization in gene therapy. Gene carriers can be broadly classified as
viral or non-viral.
Viral vectors have the advantage of supreme efficiency. The tech-
nique is based on insertion of the genetic material into the nucleic acid
strands of a modified virus by bioengineering. The virus is then in-
troduced into the body, transferring the therapeutic genetic material
as well as its own into host cells as it spreads.33c Viral vectors may
be based on adeno-viruses (AV), adeno-associated viruses (AAV) and
retro-viruses.
Problems with viral vectors include their toxicity and immuno-
genicity and difficulty of upscaling.51 Serious adverse effects in some
patients has raised concerns about the safety of this class of trans-
fection vectors.52 This has increased the recent interest in non-viral
vectors.
Non-viral delivery systems based on dendrimers, peptides and
other biopolymers, and cationic lipids have been described. These
carriers generally show lower toxicity and immunogenicity, and are
easily produced in large scale. Non-viral vectors can carry more ge-
netic material than viral vectors. However, their efficiency is low com-
pared to viral vectors. In general, non-viral vectors are hydrophobic
and cationic, and their function depends on the formation of lipophilic
complexes — lipoplexes.
2.4.2 Nucleic acid delivery via lipoplexes
Cationic lipids coordinate to negatively charged nucleic acids in a self-
assembly process driven by electrostatic attraction and hydrophobic
interactions. The geometry of the lipoplex depends on among other
factors the vector to nucleic acid ratio, and the presence of co-lipids.
Pungente18 hypothesized that structurally rigid lipids (e.g. based on
carotenoids or steroids) are packed into more dense lipoplexes. Fre-
quent geometries are lamellar and inverted hexagonal packing. The
effect of packing geometry on transfection activity is under debate.
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Lipoplexes are internalized by the target cells by endocytosis,
forming an intracellular vesicle. Endosomal escape by the nucleic acids
is instrumental to prevent lysis of the genetic material in a matured
lysosome. It has been suggested that endosomal escape is assisted by
cationic lipids by an invertion of the endosomal membrane.53
Cationic lipid derivatives of α-tocopherol were recently reported
as a potential cationic lipid gene transfection vector.20 This also sug-
gests the use of rigid tocopherol analogues like 1 as gene transfection
vectors. 1 is easily derivatized to a cationic lipid, allowing a structure-
activity study to test the hypothesis of Pungente et al.18
2.5 Microwave technology in organic synthesis54a
The use of microwaves in replacement of conventional laboratory heat-
ing was first reported in 1986.55,56 Over the previous decades, de-
velopment of designated vessels and microwave reactors have greatly
improved the safety and reproducibility of the technique. Today, the
technology has established itself in both industrial and academic use.
The main advantage of microwave irradiation is a great reduction
in reaction time. This is especially desirable from the viewpoint of a
carotenoid chemist, as carotenoid reactions are plagued by long reac-
tion times facilitating decomposition. Decrease in reaction time thus
also may improve reaction yields. One other advantage may be im-
proved purity of the crude product, as improved temperature control
also controls side product formation. This would simplify subsequent
purification steps. These advantages of course require detailed opti-
mization of the reaction conditions. Only a few examples of microwave
assisted syntheses with carotenoids have been reported.57,58
The microwave area of the electromagnetic spectrum ranges from
wavelengths between 1 cm and 1 m. According to relation 2.3, longer
wavelengths (λ) correspond to lower energy (E). c is the speed of light
in vacuum and h is Planck’s constant.
E = hc
λ
(2.3)
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Microwave photons do not have sufficent energy to directly cause
chemical reactions, in contrast to UV or visible photons in photochem-
istry. The efficiency of microwave irradiation to facilitate reactions is
rather owed to dielectric heating. In short, dielectric heating is gener-
ation of heat by molecular friction and collisions caused by the effort
of a molecular dipole to align with an oscillating electric field. An
example is the electric field component of microwave electromagnetic
radiation. Any ions present in the field will also begin to oscillate,
generating additional thermal energy in the irradiated matrix. So,
the presence of any polar or charged species in the reaction mixture
will facilitate heating by microwave irradiation.
Compared to conventional thermal heating, microwave irratiation
is much faster. External heating depends on heat transfer from the
surroundings to the reaction mixture. This transfer of energy is often
inefficient, and may cause temperature gradients and local overheat-
ing, causing decomposition of solutes. Microwave irradiation, on the
other hand, causes the bulk reaction mixture itself to warm up inter-
nally. Internal heating may lead to reaction temperatures even higher
than the solvent boiling point, thus decreasing the reaction time com-
pared to thermal heating according to the Arrhenius equation (2.4):
k = Ae−Ea/RT (2.4)
where k is the rate constant of a chemical reaction with activation
energy Ea at temperature T , A is the pre-exponential factor and R
is the Universal gas constant. An inverted temperature gradient may
also result from internal heating, and thus the design of the reaction
vessel is crucial to maintaining a uniform heat distribution.
It is sometimes observed that the product distribution of a re-
action differs whether the reaction mixture has been heated under
conventional reflux or microwave conditions. The change may be in
both chemo-, regio- and stereoselectivity. This has been rationalized
through so-called microwave effects by some authors, but the exis-
tance and impact of such effects is under debate.59–63 Suggested ther-
mal microwave effects include superheating of solvents, avoidance of
temperature gradients, and selective heating of solutes with a strong
microwave absorption.
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Non-thermal effects, more controversial and far less widely
accepted than thermal effects, are defined by Kappe and Stadler54b
as
“accelerations of chemical transformations in a microwave
field that cannot be rationalized in terms of either purely
thermal/kinetic or specific microwave effects.”
An example of such an effect is a change in the factors A and the
entropy term of Ea in the Arrhenius equation, due to the alignment
of dipoles in the electromagnetic field. It has also been suggested that
the electromagnetic field stabilizes the development of charges in non-
concerted reaction mechanisms, thus lowering the activation energy
of the reaction.59,60 Opponents of this view however argue that ther-
mal agitation should override any statistically significant alignment of
dipoles in the field.61,62
2.6 Reaction theory and mechanisms
2.6.1 Carbonyl reduction by hydride-donor reagents64a
Boron and aluminium hydride reagents are most commonly used for
hydride reduction of carbonyl groups. The simplest ones are NaBH4
and LiAlH4, the latter being the strongest reducing agent. The re-
activity of the hydride reagents can be fine-tuned by exchange of
the counterion, and by derivatization to alkyl- or alkoxylithium or
-borohydrides. Examples (figure 2.8) are diisobutylaluminium hydride
(DiBAlH, 23) and sodium bis-(2-methoxyethoxy)aluminium hydride
(Red-Al®, 24). It is also possible to introduce stereospecificity in the
reducing agent through alkyl or alkoxy derivatization.
OOAlOO
H H
Na
Al
H
23 24
Figure 2.8: The structures of DiBAlH (23) and Red-Al® (24).
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All hydrides in the reductant can be transferred to the substrate
carbonyl group. The reaction mechanism involves coordination of the
carbonyl group to a metal cation, thereby activating it for nucleophilic
attack of a hydride. The resulting aluminium alkoxides are hydrolyzed
to the corresponding alcohols and Al(OH)3 at the end of the reaction
time.
Highly oxidized carbonyls like acids and esters, are first reduced to
aldehydes, and then further to alcohols. Aldehydes are more reactive
to reduction than acids and esters, so it is challenging to stop the
reduction at the aldehyde. Acids initially consumes one additional
equivalent of hydride, generating one equivalent H2 gas.
The general reaction mechanism for reduction of an acid by a
lithium aluminium hydride reagent is shown in figure 2.9. R can be
any alkyl or alkoxy group, and R′ can be any alkyl or aryl group.
R' O
O
H H AlHR2
Li
- H2 R'
O
O
Li
R'
O
OAlR2
Li
H
- LiOAlR2 R'
O
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O
H
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R' H
O AlHR2Li Etc.
O Al O
R R
R'R'
Li H2O
R' OH
R'CO2H
+ Al(OH)3
+ ROH
+ LiOH
AlR2
H
Figure 2.9: Reaction mechanism for reduction of an acid by a lithium alu-
minium hydride reagent.
2.6.2 The Swern oxidation
Oxidation of alcohols to aldehydes by electrophile activated DMSO
was first reported in 1965.65 Swern later reported that oxalyl chlo-
ride ((COCl)2) was the most efficient activator of DMSO.21 Other
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ways of activating sulfoxides or using activated sulfinimides have been
reported later,66 but the Swern oxidation is still the most popular
method for DMSO based oxidations, due to the low cost and rela-
tively low toxicity of the required reagents.
The Swern oxidation mechanism is given in figure 2.10.2164,b,67
R may be any alkyl or aryl group. The initial activation of DMSO
is facilitated by the significantly dipolar character of the S–O bond,
and driven by the liberation of CO and CO2 by decomposition of
oxalyl chloride. After the addition of the alcohol to the sulfoxonium
species, addition of base generates an unstable sulfur ylide. This ylide
decomposes to eliminate the corresponding aldehyde. Base is also
required to quench the generated hydrochloric acid.
S O Cl
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OSCl ClSCl
- CO
- CO2
RCH2OH
S O
R
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- HNEt3Cl S O
R
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- SMe2 R
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Figure 2.10: The mechanism of the Swern oxidation.
The Swern oxidation is very sensitive to temperature changes. The
standard conditions suggested are at −78 ◦C. Maintaining a low tem-
perature is very important to minimize side reactions. Examples of a
common side reaction is the formation of mixed thioacetals by rear-
rangement of the sulfur ylide (figure 2.11).67
S O
R
O RS
Figure 2.11: A common side reaction to the Swern oxidation, forming
thioacetal byproducts.
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2.6.3 The Dess-Martin oxidation
Oxidation of primary and secondary alcohols to their corresponding
carbonyl compounds by a pentavalent iodine compound 25 is a very
mild oxidation method. It was first reported by Dess and Martin in
1983,68 and so the reagent is called Dess-Martin periodinane.
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- AcOH
+
R
O
25
Figure 2.12: The mechanism of the Dess-Martin oxidation.
The mechanism of the Dess-Martin oxidation is shown in figure
2.12.64b R can be any alkyl or aryl group. The reaction proceeds by
exchange of acetate with the alcohol, followed by decomposition of the
resulting alkoxyperiodinane, liberating the aldehyde and acetic acid.
Periodinane is reduced to acetoxyiodinane in the process. Workup of
base-sensitive compounds can be performed with sodium thiosulfate
to reduce the resulting acetoxyiodinane to sodium 2-iodobenzoate.21
I
O
O
OAc
OAc
AcO
H2O
I
O
O
OAcO
+ 2 AcOH
25 26
Figure 2.13: Hydrolysis of 25 generates the more active reagent 26.
It has been shown that the Dess-Martin oxidation is greatly accel-
erated by the addition of water.69 It is believed that water hydrolyzes
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25 in situ to the more effective reagent 26 (figure 2.13). For this rea-
son, the Dess-Martin oxidation is most frequently performed in water
saturated solvents, or with the addition of H2O.
2.6.4 The Wittig reaction64c
The classical Wittig reaction is a very useful method for creating C=C
bonds. It involves the conversion of carbonyl compounds to olefines
by the reaction of a phosphorous stabilized carbanion (a phosphonium
ylide). The Wittig reaction is of tremendous importance in carotenoid
chemistry, as it efficiently allows the formation of C=C bonds promi-
nent in the carotenoid structure.70
The general mechanism of the Wittig reaction with an aldehyde
is shown in figure 2.14. R and R′ are alkyl or aryl groups, and X is a
halogen. B is a general base. Under strongly basic conditions, a phos-
phonium salt is deprotonated generating the phosphonium ylide. The
ylide then reacts with the carbonyl compound to produce a cyclic
oxaphosphetane intermediate. The mechanism for the formation of
this intermediate is open to question. It may be formed by direct
cycloaddition between the ylide and the carbonyl,71 or it may be
formed via a dipolar betaine intermediate from nucleophilic addition
to the carbonyl group.72 The oxaphosphetane subsequently decom-
poses into phosphine oxide and the desired alkene. The driving force
is the formation of the very thermodynamically stable P=O bond.
The Wittig reaction may also be performed using an epoxide to
mediate the reaction.73 This procedure is very mild, as no base is
required. The formation of the ylide by 1,2-epoxybutane is shown in
figure 2.15.
The stereoselectivity of the Wittig reaction74
The stereochemical outcome of the Wittig reaction is thought to be
dependant on steric effects in the formation of the oxaphosphetane in-
termediate (figure 2.14). Stabilized ylides contain electron withdraw-
ing groups that contribute to stabilizing the carbanion. Stabilization
decreases the reactivity (increases the stability) of the ylide, and so
the transition state for oxaphosphetane formation will be late and
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Ph3P R
X H B
Ph3P R Ph3P R- HBX
R' H
O
Ph3P O
R R'
Ph3P O
R R'
Betaine
Oxaphosphetane
Ph3P O+R'R
Figure 2.14: The general mechanism for the Wittig reaction with an alde-
hyde.
Ph3P R
X
Ph3P R Ph3P R
O
Ph3P R
O
X
H
Figure 2.15: Epoxide mediated ylide formation.
product-like according Hammond’s postulate.75 Accordingly, the en-
ergy of the transition state is governed by steric strain in the rigid,
cyclic transition state. As illustrated in figure 2.16, this results in for-
mation of the trans transition stateA to minimize steric 1,2-interaction
between the substituents of the aldehyde and ylide.
Correspondingly, non-stabilized ylides are more reactive due to lack
of carbanion stabilization. Again according to Hammond’s postu-
late,75 non-stabilized ylides proceed through an earlier, more flexible
transition state. The transition state adopts a twisted conformation to
minimize 1,2- and 1,3-interactions (between the aldehyde substituent
and the ylide and phosphorous substituents, respectively), see figure
2.16. The favoured late transition state D leads to the formation of
cis product.
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Late, cis
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Early, cis
Figure 2.16: Kinetic (transition state) control of stereoselectivity in the
Wittig reaction. For late transition states, A is more stable.
For early transition states, D is more stable.
2.6.5 Hydrolysis of acetals76a
The hydrolysis of acetals is rapid and driven by a favourable equilib-
rium, liberating the alcohol(s) used for acetal formation. The hydro-
lysis usually exhibits specific acid catalysis. A general mechanism for
the acid catalysed hydrolysis of an acetal is shown in figure 2.17. R
may be H or any alkyl or aryl group. R′ is normally an alkyl group.
The R′ groups may also be connected to form five or six member ringed
cyclic acetals (i.e. from a diol). Initially, the acetal is hydrolyzed to
the corresponding hemiacetal. The hemiacetal is rapidly hydrolyzed
to the carbonyl via an intramolecular proton shift. The catalytic acid
is regenerated in the final deprotonation.
R2C
O
O
H
R2C
O
O
H
R'
R'
R'
R'
- R'OH
R2C O
R'
H2O
R2C
O
O
H
R'
H
R2C
O
O R'
H
H
- R'OH
R2C O
H - H
R2C O
Figure 2.17: General mechanism for acid catalyzed hydrolysis of an acetal.
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2.6.6 Benzoyl protection and deprotection64d,77a
Protection of alcohols by acylation is an efficient and well-explored
transformation. The mechanism is shown in figure 2.18, where X is
a halide and R may be any alkyl or aryl group. The benzoyl group
is imposed on the alcohol by nucleophilic addition-elimination with
a benzoyl halide. The reaction is catalyzed by pyridine as shown
or (even more efficiently) by 4-(dimethylamino)pyridine (DMAP).78
Pyridine is a stronger nucleophile than the alcohol, but the rate of
alcohol addition to the acyl pyridinium ion is far greater than the rate
of addition to the acyl halide. The presence of base is also required
to quench liberated hydrogen halide acid.
Ph X
O
N Ph N
O X
Ph N
O
X
ROH
- HX
Ph N
O OR
Ph OR
O
N+
Figure 2.18: Mechanism for benzoylation of a general alcohol with pyridine
catalysis.
Cleavage of benzoyl ethers is often performed by hydrolysis under
basic conditions. A mild deprotection method of protected carotenoids
with DiBAlH has been reported to leave the polyene chain intact.26
The mechanism of this deprotection step goes via an addition of hy-
dride to the benzoyl carbonyl, and subsequent elimination of the al-
cohol to form benzaldehyde as a byproduct. This is in analogy to the
mechanism for hydride-donor reductions in section 2.6.1.
2.6.7 Silyl protection and deprotection64d,77b
Introduction of silyl ethers as protective groups for alcohols proceeds
by nucleophilic attack by the alcohol at a substituted silyl halide, lib-
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erating hydrochloric acid. The reaction is catalyzed by tertiary amines
like imidazol, in a manner analogous to acylations in the previous sec-
tion. The amine is also required to quench liberated acid. A general
mechanism for the formation of silyl ethers is shown in figure 2.19. R
and R′ may be any alkyl or aryl group, X is a halogen.
R3Si X
X
R'OH
- HXN
NH
N SiR3HN
SiR3R'O N NH+
Figure 2.19: Mechanism for silylation of a general alcohol with imidazol
catalysis.
Deprotection of silyl ethers is commonly facilitated by tetrabuty-
lammonium fluoride. The driving force is the formation of the thermo-
dynamically stable Si–F bond. The mechanism proceeds by fluoride
ion displacement of the alcohol by a nucleophilic attack at Si. How-
ever, the fluoride ion is a very strong base, particularly under anhy-
drous conditions, and may decompose sensitive moieties like carotenoid
polyene chains. An alternative deprotection method with DiBAlH has
been reported.79
2.6.8 Benzyl protection and deprotection64d,77c
The classical Williamson reaction between an alcohol and a benzyl
halide, forming a benzyl ether, is a convenient way of protecting alco-
hol functionalities. The general mechanism is shown in figure 2.20. R
may be any alkyl or aryl group, X is a halogen, and B is a base. By
using a weak base, e.g. K2CO3, selectivity for phenols over alkyl alco-
hols may be achieved. This is owed to the greater acidity of phenolic
protons.
R OH
B
R O X Ph R O
Ph
+ HBX
Figure 2.20: Mechanism for the Williamson synthesis of benzyl ethers.
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The cleavage of benzyl ethers is most often performed by reduc-
tive hydrogenolysis. When this is not an option, as with unsatu-
rated carotenoids, alternatives include dissolving-metal reductions or
treatment with Lewis acids like BBr3. It is however not certain that
carotenoid substrates will survive under such conditions.
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Results and Discussion
3.1 Synthesis of 2-hydroxymethyl-2,5,7,8-tetra-
methylchroman-6-ol (8)
The chromanol alcohol 8 was synthesized by reduction of Trolox (7)
with Red-Al® (NaAlH2(OCH2CH2OCH3)2, 24) according to the pro-
cedure previously employed by Schiefer,80 see figure 3.1, table 3.1.
The experimental description is given in 6.2. The reaction mechanism
is outlined in section 2.6.1.
O
HO
OH
O
HO
OH
O7 8
5 eq 24, THF
1. 0 °C, 10 min
2. RT, 90 min
Figure 3.1: Synthesis of 8.
The reaction proceeds readily under dry conditions and N2 atmo-
sphere. Upon quenching with aqueous HCl, hydrogen gas is liber-
ated by excess reduction agent in an exothermic reaction according
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Table 3.1: Yields and conditions for the synthesis of 8.
Attempt Scale (g 7) Reaction conditions Yield (%)
1 1.500 Conc. 7 = 60 mg/mL 66
Red-Al added over 10 min
2 3.108 Conc. 7 = 60 mg/mL 85
Red-Al added over 10 min
3 5.000 Conc. 7 = 60 mg/mL 21
Red-Al added over 15 min
4 5.353 Conc. 7 = 37 mg/mL 95
Red-Al added over 20 min
to equation 3.1. The alkoxyhydride aluminate is converted to spar-
ingly soluble Al(OH)3, which is dissolved and removed during acidic
workup with aqueous HCl (equation 3.2).81
Na(MeOEtO)2AlH2 + HCl + 3H2O→
Al(OH)3(s) + 2H2(g) + 2ROH + NaCl
(3.1)
Al(OH)3(s) + 3HCl→ AlCl3(aq) + 3H2O (3.2)
In most attempts the reaction gives high yields of 8. In attempt 4
(table 3.1), crude product purity was assessed by TLC and 1H NMR
(appendix A, figure A.2) and found to be high enough to make purifi-
cation unnecessary.
Attempt 3 however did afford low yields, and the crude product
was discoloured by a reddish brown contaminant. In this case, the
product was purified by recrystallization from petroleum ether. The
poor results from attempt 3 were caused by the accidental use of an
old bottle of Red-Al® reagent. The reagent is sensitive to degrada-
tion by atmospheric moisture (equation 3.1), forming precipitation of
white Al(OH)3 over time even when stored under septum in containers
sealed by the manufacturer. Decomposition also leads to an increase
in viscosity of the already viscous reagent toluene solution.
53
CHAPTER 3: Results and Discussion
The highest yields are observed in attempt 4. This may be an
additional effect of performing the reaction at lower concentrations
of 7 (larger volume of THF) in an attempt to counteract solubility
problems. Red-Al® solidifies at 4 ◦C, creating problems towards the
end of its addition on an ice/water cooling bath. Upon removal of
the cooling bath and consequent liquefaction of the reaction mixture,
sudden bursts of hydrogen bubbles and inhomogeneous distribution
of solid material in the reaction mixture were observed. Dilution in
combination with slower addition of Red-Al® (table 3.1) and high
speed stirring helped alleviate the problem. Very careful stepwise
removal of the cooling bath is recommended to prevent the reaction
from becoming too vigorous.
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3.2 Synthesis of 6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-carbaldehyde (9)
Initially, the synthesis of 9 by the Swern oxidation (figure 1.4) faced se-
vere problems, as discussed in the following section 3.2.1. Alternative
strategies for the transformation were attempted, including protec-
tion and deprotection. These efforts are summarized in figure 3.2, and
discussed more thoroughly in sections 3.2.2–3.2.4. Oxidation of 8C
by CrO3·2C5H5N (Collins reagent) has been reported,82 but was not
considered due to the health hazards associated with chromium(VI).
O
HO
OH
8
O
BnO
OH
8C
O
TBDMSO
OH
8A
O
HO
O
9
O
HO
OTBDMS
8B
OO
O
27
(a)
1. (b)
(d) 1. (b)
2. (e)
(f)
2. (c)
(c)
Figure 3.2: Alternative strategies to 9. (a) 1. TBDMS-Cl, imidazol, DMF.
2. HCl, MeOH.83,84 (b) DMSO, (COCl)2, NEt3, CH2Cl2,
−78 ◦C.21 (c) TBAF, THF.85 (d) BnCl, 18-crown-6, 30,
K2CO3, acetone.86 (e) BBr3, CH2Cl2.77d (f) Dess-Martin pe-
riodinane, H2O, CH2Cl2.68,69
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3.2.1 The Swern oxidation
The chromanol aldehyde 9 was synthesized from (8) by means of the
Swern oxidation (figure 3.3). Experimental details are found in section
6.4.2. The mechanism for this reaction is given in figure 2.10 and
discussed in section 2.6.2. Yields and conditions of various attempts
are shown in table 3.2.
O
HO
OH
O
HO
O
8 9
1. (COCl)2, DMSO
    CH2Cl2, -78 °C
2. NEt3
Figure 3.3: Synthesis of 9.
The Swern oxidation of chromanol alcohol 8 to 9 has been re-
ported previously with a yield of 24%,80 and with unreported yield.87
It is apparent from table 3.2 that the oxidation is troublesome. Early
attempts according to the procedure of Schiefer afforded a yellow oil,
whereas 9 is reported to be crystalline and white.80 1H NMR evalu-
ation showed the product formed in the first attempt was a complex
mixture of products, containing a considerable amount of DMSO.
The reaction was repeated (attempt 2) under more carefully con-
trolled conditions under septum (and N2 atmosphere, as in attempt
1), with addition of reagents by syringe. The intention was to min-
imize the apparatus and the possibility for leakage and exposure to
atmospheric oxygen. Oxalyl chloride ((COCl)2) is sensitive to de-
composition by hydrolysis, as are several of the intermediates in the
reaction mechanism (figure 2.10). However, these efforts did not result
in any improvement.
In the following attempts the amount of oxidizing reagents was
increased to the point of decomposition of the reaction mixture. The
ratio of oxalyl chloride to DMSO was additionally increased, but no
advancement was made. One large-scale attempt (attempt 6) aimed
to produce a sufficient amount of 9 for characterization, but the com-
plexity of the product mixture made purification a daunting task.
As discussed in section 2.6.2, the Swern oxidation is sensitive to
56
3.2. Synthesis of 9
Table 3.2: Yields and conditions for the synthesis of 9.
Attempt Scale Reaction conditions Yield
(mg 8) (%)
1 200 1.1 eq (COCl)2, 2.4 eq DMSO,
5 eq NEt3, CO2/acetone
0
2 100 As in attempt 1, with septum
and add. by syringe
0
3 201 5 eq (COCl)2, 5 eq DMSO, 10
eq NEt3, CO2/acetone
5a
4 206 10 eq (COCl)2, 2.5 eq DMSO,
15 eq NEt3, CO2/acetone
–b
5 100 5 eq (COCl)2, 1 eq DMSO, 10
eq NEt3, CO2/acetone
20c
6 1005 1.5 eq (COCl)2, 3 eq DMSO,
5 eq NEt3, CO2/acetone
–d
7 500 1.1 eq (COCl)2, 2.4 eq DMSO,
5 eq NEt3, CO2/Et2O
28
8 1000 1.2 eq (COCl)2, 2.4 eq DMSO,
5 eq NEt3, CO2/Et2O
65
9 2500 As in attempt 8 51
aPurified by TLC
bDecomposed rapidly
cCrude
dComplex mixture
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temperature conditions. Elevation of the temperature leads to the
formation of mixed thioethers in preference to the desired aldehyde.67
Based on this, attempts were made at lower temperature. Exchange of
the CO2/dry ice cooling bath with CO2/diethyl ether (Et2O) resulted
in formation of the desired aldehyde 9 in satisfying yields and good
purity. The crude product was in some attempts still a yellow oil, but
formed white crystals after purification.
9 was purified by flash chromatography on silica or TLC. Schiefer80
also suggests recrystallization from hexane/acetone as a suitable me-
thod for purification. Initially, purification was performed with te-
dious acetone/hexane gradient elution and did not give good separa-
tion. A change of eluent to ethyl acetate in CH2Cl2 (2%) gave good
separation, and eluted 9 first from the column.
3.2.2 Silyl ether protection and deprotection
The difficulties of synthesizing 9 discussed in section 3.2.1 might be
due to the reactivity of the phenolic group of 8 and consequent forma-
tion of byproducts. Therefore, pre-oxidation protection of the phenol
was attempted.
Silylation involved protection of the phenol with TBDMS-Cl by
imidazol catalysis (figure 3.4). The mechanism for silylation of alco-
hols is given in figure 2.19 (section 2.6.7) and the experimental de-
scription in section 6.3.1.
O
HO
OH
8
O
TBDMSO
OH
8A
O
TBDMSO
OTBDMS
TBDMS-Cl, imidazol
Dry DMF, N2
HCl (1%) in
CH3OH
Figure 3.4: Synthesis of 8A.
The transformation is a two-step reaction, and was intended to be
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performed without purification of the intermediate disilylated chro-
manol alcohol. This is the reason for the twofold excess of silylation
agent. The second step is based on the selective acidic hydrolysis of
primary silyl enol ethers, as described by Davies et al.84 Under these
conditions, aromatic silyl ethers are quite stable.
The reaction between 8 and TBDMS-Cl with imidazole proceeded
smoothly in dry DMF overnight. A small sample of the crude prod-
uct was purified by TLC for evaluation by 1H NMR (appendix B,
figure B.1). The analysis showed only the primary hydroxy group had
reacted with TBDMS-Cl to form 8B (structure in figure 3.2).
Preferential silylation of the primary hydroxy group may be ex-
plained by the sterical situation of the phenolic group. The steric
bulk of tert-butyldimethylsilyl group is too large for the hindered nu-
cleophile to approach the silicon atom. Extensive silylation of the
primary hydroxy group is not surprising, as the nucleophilicity of pri-
mary alcohols is larger than for phenols, owing to the delocalization
of phenoxy electrons in the aromatic system.76b
Deprotection by TBAF
As protection of the primary alcohol is of no interest, an attempt was
made to recover the chromanol 8 from 8B. This was endeavoured
by treatment of 8B with tert-butylammonium fluoride, as shown in
figure 3.5. The mechanism is discussed in section 2.6.7.
O
HO
OH
8
O
HO
OTBDMS
TBAF
THF
8B
Figure 3.5: Deprotection of 8B.
This method was used by Atkinson et al.4 in their final step to
the unsaturated α-tocopherol analogue α-T6 (yield 38%, see section
1.1). The polyene chain of α-T6 was reported to be intact. No 8 was
formed, due to the extensive decomposition of the reactants. Reaction
time (2 h by Atkinson et al., 4 h in the current attempt) may be one
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explanation of the decomposition. The fluoride ion is a strong base,
particularly in organic solvents. This may contribute to side reactions
and decomposition.77e
3.2.3 Benzyl ether protection and deprotection
Benzylation is another method to protect the phenol group in 8 as
exemplified by Acuña et al.86 (figure 3.6). The mechanism is shown
in figure 2.20, section 2.6.8. The experimental description is given in
section 6.3.3.
O
HO
OH
8
O
O
OH
BnCl, K2CO3, KI
18-crown-6 (cat.)
Acetone, N2, reflux
8C
Figure 3.6: Synthesis of 8C.
The reaction progress was monitored by TLC, until decomposition
after 96 h without any formation of 8C.
The reaction is mediated by a weak base in order to make it se-
lective for the more acidic phenolic group, as achieved for 8 earlier by
Cohen et al. (97% yield).82 Addition of KI and 18-crown-6 catalyzes
the reaction. In polar aprotic solvents like acetone, K+ is selectively
solvated, increasing the distance to the anion. This naked anion effect
is enhanced by the addition of 18-crown-6, forming complexes with
the cation (illustrated in figure 3.7).
O
OO
O
O
O
K+K+
O
O
OO
O
O
I
I
Figure 3.7: Selective solvation and complexation of K+ by 18-crown-6 in
acetone.
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One consequence of the naked anion effect is improved solubil-
ity of the inorganic salt in organic solvents. More importantly, the
nucleophilicity of the anion I– is increased, causing displacement of
chloride and in situ generation of benzyl iodide. Iodide, being a bet-
ter leaving group than chloride, thus increases the rate of attack by
the alcohol and consequent product formation.64e,76c The mechanism
of this catalysis is shown in figure 3.8.
R OH
Cl Ph RO PhI
- Cl I Ph - HI
Figure 3.8: Mechanism for catalysis of the formation of 8C by KI.
Subsequent deprotection of the phenol was to be performed with
a Lewis acid like BBr3,77d although the substrate might not be stable
to this treatment.
3.2.4 The Dess-Martin oxidation
The Dess-Martin oxidation with periodinane was an alternative at-
tempt to oxidize 8 to 9. The general mechanism is shown in figure
2.12 (section 2.6.3), and the experimental procedure is given in section
6.4.1. Product 9 was not formed (figure 3.9).
O
HO
OH
8
O
HO
O
9
OO
O
27
I
O
O
OAc
OAcAcO 25
CH2Cl2, H2O, RT
Figure 3.9: Attempted Dess-Martin oxidation of 8. 27 was formed in
favour of expected 9.
The reaction proceeds smoothly in aqueous CH2Cl2 and gives pure
27 as the only product in good yields. The reaction was performed
twice to determine whether the conditions affected the chemoselectiv-
ity. These attempts are summarized in table 3.3. No attempts were
made in which the periodinane 25 was hydrolyzed to 26 (figure 2.13)
before addition of 8.
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Table 3.3: Yields and conditions for the synthesis of 27.
Attempt Scale Reaction conditions Yield
(mg 8) (%)
1 100 2.5 eq 27, 2.5 eq H2O in dry
CH2Cl2, 4.5 h. NaOH workup
52
2 100 1.5 eq 27, H2O sat. CH2Cl2,
1 h 40 min. Na2S2O3 workup
71
1H NMR (appendix C, figure C.2) clearly showed that the aldehyde
9 had not been formed by the absence of the aldehydic proton signal
around δ 9.5 ppm. Further NMR experiments and characterization
by MS and IR elucidated 27 (section 5.3 and appendix C).
The p-hydroquinone-like chroman system of 8 was oxidized to a
p-quinone-like tocophorone by the Dess-Martin periodinane 25 (fig-
ure 3.9). This transformation occurs in preference to the oxidation
of the primary hydroxy group. The precise origin of this chemoselec-
tivity is not clear. The same transformation has been achieved with
cerium(IV) sulphate.82 Similar oxidation products of tocopherols have
been reported,32b,88,89 including the oxidation of α-tocopherol to “α-
tocopheroxide” (28). 28 may be regarded as an acetal of the corre-
sponding p-tocophorone (29, see figure 3.10). The oxidation is per-
formed by FeCl3, tetrachloro-o-quinone or N -bromosuccinimide in the
presence of alcohols. 27 may similarly be regarded an intramolecular
acetal of a p-tocopherone.
O
HO
C16H33 O
O
C16H33O R
O
O
C16H33
OH
+ ROH282
[ox]
29
Figure 3.10: Oxidation of α-tocopherol to “α-tocopheroxide”. Reported
oxidizing agents are FeCl3, tetrachloro-o-quinone or N -
bromosuccinimide.
A tentative mechanism for the oxidation of 8 to 27 is shown in
figure 3.11. It must be emphasized that this mechanism is deduced
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solely on the base of chemical rationale. Mechanistic studies have not
been performed. One objection to the proposed mechanism is the
steric stituation of the phenolic group, expected to preclude addition
of this group to the periodinane reagent.
I
O
O
OAc
OAc
AcO
25
O
HO
OH
8
I
O
O
OAcAcO
O
O
O
AcOH
H3O+
H2O
AcO
H
AcOH
OO
O
27
I
O
O
OAc
+
Figure 3.11: Tentative mechanism for the formation of 27 from 8.
3.3 Synthesis of 5-(6-hydroxy-2,5,7,8-tetra-
methylchroman-2-yl)-2-methylpenta-2,4-di-
enal (11)
In a Wittig reaction, phosphonium salt 10 was reacted with 9 to form
11 according to the two procedures in figure 3.12. A general mecha-
nism for the reaction is shown in figures 2.14 and 2.15. Subsequent
hydrolysis of the resulting acetal afforded 11 (mechanism in figure
2.17). The experimental procedures are given in section 6.5. Table
3.4 gives an overview of the conditions and yields of various attempts.
Some initial attempts to run the reaction with crude 9 from failed
Swern oxidation attempts resulted in complex product mixtures. As
purification would be a daunting endeavour, the crude products were
not purified. Later TLC co-chromatography with a pure sample of 11
showed that reaction 2 afforded a small amount of product.
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Table 3.4: Yields and conditions for the synthesis of 11.
Attempt Scale Reaction conditions Yield
(mg 9) (%)
1 20a 10 eq 10, MeOK (10 eq),
MeOH, CH2Cl2, MW (80 W,
20 min)
–b
2 100c 10 eq 10, MeOK (10 eq),
MeOH, CH2Cl2, reflux (21 h)
–d
3 55 10 eq 10, MeOK (10 eq),
MeOH, CH2Cl2, MW (80 W,
20 min)
–e
4 20 5 eq 10, MeOK (5 eq), MeOH,
CH2Cl2, reflux (114 h)
–e
5 20 5 eq 10, 1,2-epoxybutane,
EtOH, MW (320 W, 1 h 10
min)
–e
6 20 5 eq 10, 1,2-epoxybutane,
EtOH, reflux (72 h)
–e
7 100 5 eq 10, MeONa (5 eq),
MeOH, CH2Cl2, reflux (20 h)
33
8 50 2.6 eq 10, MeONa (6.1 eq),
MeOH, CH2Cl2, MW (80 W,
20 min)
–e
9 389 5 eq 10, MeONa (5 eq),
MeOH, THF, reflux (22 h)
26
10 504 5 eq 10, MeOK (5 eq), MeOH,
CH2Cl2, MW (90 W, 26 min)
19
aCrude, from early attempt of Swern oxidation
bNot purified due to complexity of product mixture
cImpure, from early attempt at Swern oxidation
dVery low. Used for qualitative TLC assessment of methods
eUsed for qualitative TLC assessment of methods
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O
HO
O
H
O
HO
O
O
OPh3BrP
10
1. MeOK, MeOH, CH2Cl2
    reflux or MW
2. p-TsOH, CH2Cl2
O
HO
O
H
O
HO
O
1. 10, 1,2-epoxybutane,
    EtOH, reflux or MW
2. p-TsOH, CH2Cl2
9 11
119
Figure 3.12: Synthesis of 11.
Each method was optimized in small scale (table 3.4, attempts
3–6). Conditions for the microwave reactions were chosen in collab-
oration with Ph.D. candidate Muhammad Zeeshan, who had experi-
ence in microwave Wittig reactions.90 The crude products were com-
pared by TLC co-chromatography. After analysis, the combined crude
products were purified by flash column chromatography, as described
below, to afford a common batch of 11.
The mild method mediated by 1,2-epoxybutane proved to be inef-
ficient, as the reaction mixture still contained a substantial amount of
starting material. This may be due to the steric hindrance imposed
on aldehyde 9 by the quaternary α-position. As product to byprod-
uct ratios seemed similar to the base mediated method, the epoxide
mediated method was rejected for this step. However, it might be in-
teresting to consider this method for the subsequent second elongation
in future work.
A base driven reaction under microwave conditions was selected
for further development. This decision was based on the full con-
version of starting material 9 in these attempts, and the shortening
of reaction time from ca. 20 h to 20–25 min compared to refluxing.
Some variations of base and solvent were examined in late attempts,
but admittedly not investigated systematically enough to make any
conclusions as to their affect on the reaction outcome.
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The hydrolysis of the intermediate acetal formed in most cases
proceeded rapidly. 11 was even found to be present in the crude in-
termediate pre-hydrolysis (minor hydrolysis of the acetal under basic
conditions). In a few cases, the reaction was very sluggish or did not
proceed. In the case of attempt 3, even refluxing the crude intermedi-
ate with p-toluenesulfonic acid for 20 h did not completely hydrolyze
the product. A milder method with citric acid in methanol (30%) and
refluxing for 26 h proved to be successful (section 6.5.5).
Chromatographic workup of crude 11 proved to be a demand-
ing task. Gradient elution is required due to the small differences in
polarity between the starting material and product. In eluent sys-
tems based on ethyl acetate in hexane, the product spot showed two
compounds of almost identical polarity. Detailed development of a
tertiary eluent system ((2 : 1 CH2Cl2 : ethyl acetate)/hexane) with
gradient elution afforded separation. 1H NMR analysis showed they
were cis/trans isomers, the cis isomer being the most nonpolar frac-
tion. The analysis is detailed in section 5.5. NMR spectra are given
in appendix E.
Cis/trans isomers were separated and the cis : trans ratio was
found to be 72 : 28 for attempt 9, and 37 : 63 for attempt 10. As the
ylide from 10 is stabilized by delocalization, formation of the trans iso-
mer is expected to be favoured (see the discussion of Wittig reaction
stereoselectivity in section 2.6.4). The stereochemical preference, al-
though modest, is reversed in the two attempts without any apparent
reason.
3.4 Synthesis of 9-(6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-yl)-2,6-dimethylnona-2,4,6,8-tetra-
enal (12)
Compound 12 has been synthesized from 11 by a microwave Wittig
reaction with phosphonium salt 10 and following hydrolysis of the
intermediate acetal with p-toluenesulfonic acid (figure 3.13). Mecha-
nisms are given in figures 2.14 and 2.17. The experimental description
is given in section 6.6. Table 3.5 shows conditions and yields for the
different attempts.
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O
HO H
O
OPh3BrP
10
1. MeOK, MeOH,
    CH2Cl2, MW
2. p-TsOH, CH2Cl2
O
HO
O
H
O
H
11
12
Figure 3.13: Synthesis of 12.
The yields of the second elongation step are low since there was not
enough time to optimize the reaction conditions. The crude products
were purified by ethyl acetate/cyclohexane gradient elution, but this
system did not give good separation and the NMR spectra (appendix
F) indicated the presence of impurities. Time concerns precluded
optimization of the eluent system.
The complexity of the spectra may be attributed to the presence of
various cis/trans isomers. The reaction was performed with mixtures
of (Z )-11 and (E)-11. The intention was to isomerize the double
bonds to the more thermodynamically favourable trans geometry once
the target compound 1 had been produced. This may be achieved
by treatment of a solution of 1 with I2 in light, as shown in figure
3.14.91,92
Solutions of 12 appear orange compared to the yellow solutions
of 11. λmax increases from 275 nm to 350 nm. The colour of 12
in solution was found to be pH dependant. During workup, a sudden
change from orange to deep, intense red was observed when the organic
phase was washed with NaHCO3 solution. The colour returned to
orange when the organic phase was washed with H2O.
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Table 3.5: Yields and conditions for the synthesis of 12.
Attempt Scale Reaction conditions Yield
(mg 11) (%)
1 14 5 eq 10, MeONa (5 eq),
MeOH, THF, MW (80 W, 20
min)
–a
2 52 3 eq 10, MeONa (3.5 eq),
MeOH, CH2Cl2, MW (80 W,
25 min)
14b
3 125 3 eq 10, MeOK (3 eq), MeOH,
CH2Cl2, MW (80 W, 25 min)
7b
aPurification by TLC and identification of 12 by MS
bNot pure
O
HO
1
H H H
O
HO
1
I2, hν
Figure 3.14: Photoinduced isomerization of 1 by I2.
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3.5 Protection of 9
The Wittig synthesis of 12 had not afforded good yields. Conse-
quently, an attempt was made to protect the phenyl group of chro-
manol aldehyde 9 before retrying the Wittig reactions. Unfortunately,
the efforts to protect the phenol did not give any useful result as fur-
ther discussed in the following sections.
3.5.1 Synthesis of 2-formyl-2,5,7,8-tetramethylchroman-6-
yl benzoate (9A)
Protection of 9 by benzoylation to 9A was achieved by the method
shown in figure 3.15. The experimental description is given in section
6.7.1. Table 3.6 shows the yields achieved under different conditions.
O
HO
O
9
Pyridine
CH2Cl2, N2
O
BzO
O
9A
Cl
O
Figure 3.15: Synthesis of 9A.
Table 3.6: Yields and conditions for the synthesis of 9A.
Attempt Scale Reaction conditions Yield
(mg 9) (%)
1 145 1.1 eq BzCl, CH2Cl2, pyri-
dine, 0 ◦C, then RT
–a
2 114 1.5 eq BzCl, pyridine, RT 87b
aNot isolated or purified
bCrude
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TLC analysis of the reaction mixture from attempt 1 showed no
apparent product formation, even after 22 h of stirring. DMAP was
added to increase the reaction rate. It acts as a better catalyst of the
reaction due to additional resonance stabilization of the intermediate
acyl pyridinium ion.78 However, even after 90 h of stirring, no product
was visible by TLC. The sensitive benzoyl chloride might have been
hydrolyzed to benzoic acid. N,N′-Dicyclohexylcarbodiimide (DCC)
was then used to catalyse the esterification of possible benzoic acid
with phenol 9 (Steglich esterification, figure 3.16).64f,93 The attempt
was aborted after 114 h of total reaction time with no product forma-
tion (TLC evidence).
R OH
O
NC6H11CC6H11N R O
O
C
NC6H11
NHC6H11
R'OH
R O
O
C NC6H11
NHC6H11
OR' H
R
O
OR'
NHC6H11
NHC6H11
O
+
Figure 3.16: A general mechanism for the Steglich esterification.
The reaction was repeated with fresh benzoyl chloride. Now, the
reaction proceeded smoothly and was finished in 15 min. Upon addi-
tion of benzoyl chloride, the reaction mixture became opaque. This
was assumed to be due to formation of pyridinium salt. However, it
turned out that the product itself was precipitated. Furthermore, the
product proved to be insoluble in all common laboratory solvents. Its
identity could only be confirmed by MS analysis, run with the solid
sample. The insolubility of the product precludes purification, and
further Wittig elongation.
During the workup, one curious effect was noticed. Although the
crude product was insoluble, it was readily dispersed in liquids. When
washing the CH2Cl2 solution with H2O, the solid material distributed
over both phases. Upon acidification with HCl, the solid material
only dispersed in the organic phase. Washing with aqueous NaHCO3
resulted in the product being dispersed solely in the aqueous phase.
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3.5.2 Attempted synthesis of 6-(tert-butyldimethylsilyl-
oxy)-2,5,7,8-tetramethylchroman-2-carbaldehyde (9B)
Following the synthesis of 9A, another protection method by silylation
of the phenolic group was attempted (figure 3.17). The experimental
procedure is given in section 6.7.2.
O
HO
O
9
O
TBDMSO
O
9B
TBDMS-Cl, imidazol
Dry DMF, N2
Figure 3.17: Synthesis of 9B.
This is the protection method employed by Atkinson et al.4 in
their synthesis of α-tocopherol analogue α-T6, as discussed in section
1.1. Their procedure was followed exactly, but product formation was
not apparent by TLC after 5 h. For practical reasons, the reaction
mixture was left overnight. At the following morning the reaction had
decomposed. Due to lack of time, the protection reaction could not
be repeated.
3.6 Future work
The obvious continuation of this work is the synthesis of target mole-
cule 1 as outlined in figure 1.4. Before the final Wittig elongation step
with phosphonium salt 13, optimization of reaction conditions for the
synthesis of 12 should be performed to increase yields. Purification
methods for this step also require optimization. As mentioned in
section 3.3, the epoxide mediated Wittig reaction may be appropriate
for the synthesis of 12. The reason for this is the reduced steric
demand in the α position of the aldehyde in 11 compared to 9.
A systematic investigation of the effect of solvent or choice of base
in the Wittig synthesis of 11 may also lead to increased yields for this
step. This may also give further insight into what parameters cause a
shift in cis/trans stereoselectivity for the Wittig reaction.
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The synthesis may be extended to more homologues in this novel
chromanol carotenoid class. Variations in polyene chain length and
cyclic end groups may be beneficial for structure—activity relationship
studies of antioxidant activity and gene transfection vector efficiency.
A suggestion for an analogue library based on β-carotene, zeaxanthin
and astaxanthin is given in figure 3.18.
O
HO
n
O
HO
n
O
HO
n
OH
OH
O
n = 1-3
n = 1-3
n = 1-3
Figure 3.18: A suggested analogue library for future structure-activity re-
lationship studies.
The Dess-Martin oxidation (section 3.2.4) seemed to be a suit-
able method of oxidixing 8 to 9. Unexpectedly 27 was formed, with
chemoselective oxidation of the p-hydroquinone-like chromanol system
in preference to the primary alcohol. Further mechanistic studies of
this step could provide insight into the nature of the oxidation method,
and the reactivity of other chromanols. For the purpose of synthetic
utilization in the synthesis of 1, the Dess-Martin oxidation might as
well be worth a revisit. The transformation may be attempted in a
procedure employing hydrolysis of the reagent 25 to 26 (see section
2.6.3) prior to addition of 8, or even under anhydrous conditions.
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Conclusion
The precursor 12 of target molecule 1 has been synthesized by a
Wittig reaction with microwave irradiation.
12
O
HO
O
O
HO
1
The total yield is 3%, which is low. The reaction conditions and
purification method for the final step in the synthesis of 12 require
optimization.
11, the precursor to 12, has been synthesized by a Wittig reaction
with reflux and microwave irratiation. 11 was separated into its cis
and trans isomers by flash column chromatography. The cis : trans
ratio was found to be varying.
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O
HO
O
11
H
Attempts were made to protect the intermediate 8 by silylation to
8A and benzylation to 8C. Only 8B was formed. Similarly, efforts
were made to protect the intermediate 9 by benzoylation to 9A and
silylation to 9B. Only 9A was formed, but found to be insoluble in
all common laboratory solvents.
O
HO
OH
8
O
O
OH
8A
Si
O
HO
O
8B
Si
O
O
OH
8C
O
HO
O
9
O
O
OO
9A
O
O
O
9B
Si
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Intermediate 9 was formed from 8 by the Swern oxidation. The
Dess-Martin oxidation was also attempted, but led to the formation
of an unexpected quinone-like derivative 27.
OO
O
27
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Spectroscopy
5.1 2-Hydroxymethyl-2,5,7,8-tetramethylchroman-
6-ol (8)
The IR spectrum of 8 (appendix A, figure A.1) shows characteristic
O–H stretching at 3280 cm−1. The absence of a strong C=O stretching
signal in the 1700–1750 cm−1 region is a clear indication that the
precursor acid 7 has been fully reduced (see section 3.1).
5.1.1 NMR spectroscopy
O
HO
OH2
2a
2b
3
4
4a
5
5a
6
7a
7
8
8b
8a
8
Figure 5.1: Structure and numbering of atoms in 8.
The assignment of 1H NMR shifts (δ H), multiplicity (M) and 13C
NMR shifts (δ C) for 8 is shown in table 5.1. Coupling constants (J )
are not included as all 1H signals are either singlets or multiplets. The
numbering of the atoms is shown in figure 5.1. 1H and 13C shifts are
assigned in accordance with 1H (figure A.2), 13C (figure A.3), HSQC
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(figure A.4), HMBC (figure A.5–A.6) and COSY (figure A.7) NMR
spectra (appendix A).
Table 5.1: Assigned shifts for 8.
Carbon no. δ H (ppm) M δ C (ppm)
C-2 – – 75.20
C-2a 1.22 s 20.51
C-2b 3.69–3.55 m 69.51
C-2b–OH 2.05–1.90 sa –
C-3 2.05–1.90 m
a
28.001.77–1.69 m
C-4 2.74–2.59 m 20.38
C-4a – – 117.5
C-5 – – 118.9
C-5a 2.12 s 11.42
C-6 – – 145.2
C-6–OH 4.29 s –
C-7 – – 121.5
C-7a 2.17 s 12.31
C-8 – – 122.7
C-8a – – 145.0
C-8b 2.11 s 11.97
aOverlapping with other signals
5.1.2 MS fragmentation
MS ionization by electron impact (EI) may cause fragmentation of
the molecule. Such fragments contain important information about
the molecular structure. The LRMS spectrum by EI ionization of 8
(appendix A, figure A.8) is summarized in table 5.2. The fragments
are named in accordance with figure 5.2.
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Table 5.2: Main MS fragments of 8.
m/z Rel. intensity (%) Fragment Name
236 94 [M]+ –
218 5 [M−H2O]+ A
205 90 [M−CH3O]+ B
203 62 –
166 55 [M−C4H6O]+ –
165 100 [M−C4H7O]+ C
164 38 [M−C4H8O]+ D
121 11 [M−C6H11O2]+ –
Figure 5.2 shows possible radical ion fragments of 8. These frag-
ments contribute to confirming the identity of compound 8. The frag-
ments may be formed either by direct fragmentation of the molecular
ion or by subsequent fragmentation of a fragment. Fragmentation
may also be preceded by migrations and rearrangements.
O
HO
O
HO
OH
HO
O
HO
A B C
D
Figure 5.2: Possible radical ion fragments of 8.
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5.2 2-(tert-Butyldimethylsilyloxymethyl)-2,5,7,8-
tetramethylchroman-6-ol (8B)
O
HO
O2
2a
2b
3
4
4a
5
5a
6
7a
7
8
8b
8a
Si
8B
Figure 5.3: Structure and numbering of atoms in 8B.
The assignment of 1H NMR shifts (δ H), multiplicity (M), coupling
constants (J ) and 13C NMR shifts (δ C) for 8B is shown in table 5.3.
The numbering of the atoms is shown in figure 5.3. 1H and 13C shifts
are assigned in analogy to 8. 1H (figure B.1) and 13C (figure B.2)
NMR spectra are shown in appendix B.
Table 5.3: Assigned shifts for 8B.
Carbon no. δ H (ppm) M J (Hz) δ C (ppm)
C-2 – – – 75.31
C-2a 1.24 s – 18.37
C-2b 3.64–3.58 d 9.76 68.573.54–3.48 d 9.76
C-3 2.02–1.91 m – 28.321.80–1.71 m –
C-4 2.65–2.57 t 6.84 20.54
C-4a – – – 117.7
C-5 – – – 118.6
C-5a 2.12 s – 11.44
C-6 – – – 145.7
C-6–OH 4.19 s – –
C-7 – – – 121.2
C-7a 2.16 s – 12.35
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Table 5.3 (cont.)
Carbon no. δ H (ppm) M J (Hz) δ C (ppm)
C-8 – – – 122.6
C-8a – – – 144.8
C-8b 2.11 s – 11.97
-Si-C(CH3)3 0.91 s – 25.99
-Si-CH3
0.07 s – −5.25
0.04 s – −5.32
-Si-C(CH3)3 – – – 22.18
5.3 3,6,8,9-Tetramethyl-2,4,5-trihydro-3,9a-
epoxybenzooxepin-7-one (27)
The IR spectrum of compound 27 (figure C.1, appendix C) shows
a strong C=O stretching signal at 1629 cm−1. This wavenumber is
too low to originate from an aldehyde, but is consistent with a con-
jugated, cyclic ketone or quinone. The absence of an O–H stretching
signal around 3200–3500 cm−1 is also in accordance with the proposed
structure of 27.
5.3.1 NMR spectroscopy
O
O
3
4
5
5a
6
6a
7
8a
8
9
9b
9a
O
3a
2
27
Figure 5.4: Structure and numbering of atoms in 27.
The absence of an aldehydic signal in the δ 9–10 ppm region of
the 1H NMR spectrum of 27 (figure C.2) is an indication that the
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expected aldehyde (9) was not formed in the Dess-Martin oxidation
of 8 (see section 3.2.4).
The assignment of 1H NMR shifts (δ H), multiplicity (M), coupling
constants (J ) and 13C NMR shifts (δ C) for 27 is shown in table 5.4.
The numbering of the atoms is shown in figure 5.4. 1H and 13C shifts
are assigned in accordance with 1H (figure C.2), 13C (figure C.3),
DEPT135 (figure C.4), HSQC (figure C.5), HMBC (figure C.6–C.7)
and COSY (figure C.8) NMR spectra (appendix C).
Table 5.4: Assigned shifts for 27.
Carbon no. δ H (ppm) M J (Hz) δ C (ppm)
C-2 4.18–4.14 d 6.88 74.683.65–6.61 d 6.88
C-3 – – – 80.93
C-3a 1.42 s – 22.15
C-4 1.96–1.82 ma – 35.83
C-5 2.74–2.53 m – 22.70
C-5a – – – 147.5
C-6 – – – 126.8
C-6a 1.79 s – 10.41
C-7 – – – 185.3
C-8 – – – 134.5
C-8a 1.86 sa – 11.67
C-9 – – – 145.4
C-9a – – – 100.1
C-9b 1.90 sa – 12.91
aOverlapping with other signals
5.3.2 MS fragmentation
The LRMS spectrum by EI ionization of 27 (appendix C, figure C.9) is
summarized in table 5.5. The naming of the fragments is in accordance
with figure 5.5.
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Table 5.5: Main MS fragments of 27.
m/z Rel. intensity (%) Fragment Name
234 88 [M]+ –
216 12 [M−H2O]+ E
206 29 [M−CO]+ F
204 96 [M−CH2O]+ G
189 100 [M−C2H5O]+ H
177 21 [M−C3H5O]+ –
161 46 [M−C3H5O2]+ I
148 17 [M−C4H6O2]+ –
136 15 –
105 10 –
91 19 [M−C7H11O3]+ –
Figure 5.5 shows possible radical ion fragments of 27. These frag-
ments contribute to confirming the identity of compound 27. The
fragments may be formed either by direct fragmentation of the molec-
ular ion or by subsequent fragmentation of a fragment. Fragmentation
may also be preceded by migrations and rearrangements.
O
H
O
E
I
O O
F
O O
G
O
O
H
O
Figure 5.5: Possible radical ion fragments of 27.
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5.4 6-Hydroxy-2,5,7,8-tetramethylchroman-2-
carbaldehyde (9)
The IR spectrum of 9 (figure D.1) exhibits characteristic O–H stretch-
ing at 3535 cm−1 and a strong C=O stretching signal at 1732 cm−1.
This is in agreement with the expected oxidation of 8 to 9 by the
Swern oxidation (see section 3.2.1).
5.4.1 NMR spectroscopy
O
HO
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9
Figure 5.6: Structure and numbering of atoms in 9.
The assignment of 1H NMR shifts (δ H), multiplicity (M) and 13C
NMR shifts (δ C) for 9 is shown in table 5.6. Coupling constants (J )
are not included as all 1H signals are either singlets or multiplets. The
numbering of the atoms is shown in figure 5.6. 1H and 13C shifts are
assigned in accordance with 1H (figure D.2), 13C (figure D.3), HSQC
(figure D.4) , HMBC (figure D.5–D.6) and COSY (figure D.7) NMR
spectra (appendix D).
Table 5.6: Assigned shifts for 9.
Carbon no. δ H (ppm) M δ C (ppm)
C-2 – – 80.41
C-2a 1.38 s 21.66
C-2b 9.61 s 204.7
C-3 2.31–2.22 m 28.051.86–1.76 m
C-4 2.67–2.48 m 20.51
83
CHAPTER 5: Spectroscopy
Table 5.6 (cont.)
Carbon no. δ H (ppm) M δ C (ppm)
C-4a – – 117.6
C-5 – – 118.8
C-5a 2.06 s 11.34
C-6 – – 145.7
C-6–OH 4.30 s –
C-7 – – 121.7
C-7a 2.17 s 12.32
C-8 – – 122.9
C-8a – – 145.3
C-8b 2.20 s 12.00
5.4.2 MS fragmentation
The main fragments of 9 from LRMS by EI ionization (appendix D,
figure D.8) are shown in table 5.7. The naming of the fragments is in
accordance with figure 5.7.
Table 5.7: Main MS fragments of 9.
m/z Rel. intensity (%) Fragment Name
234 31 [M]+ –
205 100 [M−CHO]+ B
190 22 [M−C2H4O]+ J
149 13 [M−C4H5O]+ –
91 11 [M−C7H11O3]+ –
70 19 [M−C10H12O2]+ –
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Figure 5.7 shows possible radical ion fragments of 9. The loss
of CHO (fragment B) is typical to aldehydes. The fragment at m/z
91 is most likely the tropylium ion. These fragments contribute to
confirming the identity of compound 9. The fragments may be formed
either by direct fragmentation of the molecular ion or by subsequent
fragmentation of a fragment. Fragmentation may also be preceded by
migrations and rearrangements. Fragment B (m/z 205) is also seen
in the LRMS spectrum of 8, cf. figure 5.2.
O
HO
B
O
HO
J
Figure 5.7: Possible radical ion fragments of 9.
5.5 5-(6-Hydroxy-2,5,7,8-tetramethylchroman-
2-yl)-2-methylpenta-2,4-dienal (4Z-11)
The IR spectra (appendix E, figure E.1) of the cis and trans isomers
of 11 are identical. The spectrum shows characteristic O–H and C=O
stretching at 3450 and 1667 cm−1, respectively. A strong signal owing
to conjugated C=C stretching is also seen at 1630 cm−1.
Both isomers of 11 are coloured. In solution, they are both light
yellow, while as a neat liquid they are dark orange to red in colour.
The trans isomer appears darker in colour than the cis isomer. Even
so, both isomers have a UV/Vis λmax of 275 nm (figure E.2). The
theoretically calculated λmax value according to Woodward’s rules for
conjugated carbonyls is 268 nm.
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5.5.1 NMR spectroscopy
(4Z)-isomer
O
HO
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2a'
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(Z)-11
Figure 5.8: Structure and numbering of atoms in (4Z )-11.
The assignment of 1H NMR shifts (δ H), multiplicity (M), coupling
constants (J ) and 13C NMR shifts (δ C) for (4Z )-11 is shown in table
5.8. The numbering of the atoms is shown in figure 5.8. 1H and 13C
shifts are assigned in accordance with 1H (figure E.3), 13C (figure E.4),
HSQC (figure E.5–E.6), HMBC (figure E.7–E.8) and COSY (figure
E.9) NMR spectra (appendix E).
The cis isomer of 11 is distinguishable from the trans isomer by
comparison of the 3J (H,H) coupling constants. The C-4′ and C-5′
protons exhibit a coupling of 11.80 Hz in the cis isomer and 15.12 Hz
in the trans isomer (cf. table 5.9). These coupling values are typical
for cis and trans isomers, respectively.94
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Table 5.8: Assigned shifts for (4Z )-11.
Carbon no. δ H (ppm) M J (Hz) δ C (ppm)
C-2 – – – 76.77
C-2a 1.56 s – 27.79
C-3 2.15–2.01 m
a – 33.911.90–1.79 ma –
C-4 2.74–2.55 m – 21.35
C-4a – – – 117.7
C-5 – – – 119.1
C-5a 2.10 sa – 11.66
C-6 – – – 145.5
C-6–OH 4.32 s – –
C-7 – – – 121.8
C-7a 2.15 sa – 12.57
C-8 – – – 122.4
C-8a – – – 145.2
C-8b 2.20 sa – 12.62
C-1′ 9.45 s – 195.7
C-2′ – – – 139.1
C-2a′ 1.77 sa – 9.13
C-3′ 7.82–7.77 d 11.96 144.4
C-4′ 6.49–6.38 ftb 11.96 124.811.80
C-5′ 5.91–5.82 d 11.80 143.6
aOverlapping with other signals
bFalse triplet, should be interpreted as doublet of doublets
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(4E)-isomer
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Figure 5.9: Structure and numbering of atoms in (4E)-11.
The assignment of 1H NMR shifts (δ H), multiplicity (M), coupling
constants (J ) and 13C NMR shifts (δ C) for (4E)-11 is shown in
table 5.9. The numbering of the atoms is shown in figure 5.9. 1H
and 13C shifts are assigned in accordance with 1H (figure E.10), 13C
(figure E.11), HSQC (figure E.12–E.13), HMBC (figure E.14–E.15)
and COSY (figure E.16) NMR spectra (appendix E).
As mentioned in the previous subsection, the trans isomer of 11
is identified by the 3J (H,H) coupling constant of 15.12 Hz.94
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Table 5.9: Assigned shifts for (4E)-11.
Carbon no. δ H (ppm) M J (Hz) δ C (ppm)
C-2 – – – 75.45
C-2a 1.45 s – 27.00
C-3 2.05–1.84 ma – 32.47
C-4 2.71–2.43 m – 21.26
C-4a – – – 117.5
C-5 – – – 119.0
C-5a 2.09 sa – 11.62
C-6 – – – 145.4a
C-6–OH 4.50 s – –
C-7 – – – 121.7
C-7a 2.17 sa – 12.55
C-8 – – – 122.5
C-8a – – – 145.4a
C-8b 2.20 sa – 12.11
C-1′ 9.39 s – 195.4
C-2′ – – – 137.8
C-2a′ 1.75 s – 9.73
C-3′ 6.83–6.76 d 11.28 148.5
C-4′ 6.67–6.58 dd 15.12 124.111.28
C-5′ 6.28–6.20 d 15.12 147.8
aOverlapping with other signals
5.5.2 MS fragmentation
The main fragments of 11 from LRMS by EI ionization (appendix E,
figure E.17) are shown in table 5.10. The fragmentation pattern is
identical for both isomers of 11. The naming of the fragments is in
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accordance with figure 5.2.
Table 5.10: Main MS fragments of 11.
m/z Rel. intensity (%) Fragment Name
300 61 [M]+ –
205 27 [M−C6H7O]+ B
203 43 [M−C6H9O]+ –
165 100 [M−C9H11O]+ C
164 67 [M−C9H12O]+ D
136 33 –
121 24 [M−C11H15O2]+ –
91 20 [M−C12H17O3]+ –
77 11 [M−C13H19O3]+ –
Fragments B, C and D are also seen in the LRMS spectrum of
8, cf. figure 5.2. Fragment B is also seen in the LRMS spectrum
of 9. The presence of tropylium (m/z 91) and C6H+5 (m/z 77) is
also notable. These fragments contribute to confirming the identity
of compound 11. The fragments may be formed either by direct frag-
mentation of the molecular ion or by subsequent fragmentation of a
fragment. Fragmentation may also be preceded by migrations and
rearrangements.
5.6 9-(6-Hydroxy-2,5,7,8-tetramethyl-chroman-2-
yl)-2,6-dimethylnona-2,4,6,8-tetra-enal (12)
The IR spectrum of 12 (appendix F, figure F.1) shows a characteristic
O–H stretching signal at 3437 cm−1 and a C=O stretching signal at
1668 cm−1. A C=C stretching signal at 1579 cm−1 is also present.
Also notable is the presence of several weaker signals around 1600–
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1730 cm−1, some partly overlapping with the two larger signals. These
may be due to C=O and C=C stretching in minor isomers of 12.
The UV/Vis spectrum of 12 is shown in figure F.2. The λmax
of 12 is 350 nm, compared to 275 nm for the precursor 11. This
bathochromic shift is a clear indication that the lenght of the polyene
chain has been increased. The theoretically calculated λmax value
according to Woodward’s rules for conjugated carbonyls is 346 nm.
5.6.1 NMR spectroscopy
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Figure 5.10: Structure and numbering of atoms in 12.
The assignment of 1H NMR shifts (δ H), multiplicity (M), coupling
constants (J ) and 13C NMR shifts (δ C) for 12 is shown in table 5.11.
The numbering of the atoms is shown in figure 5.10. 1H and 13C
shifts are assigned in accordance with 1H (figure F.3), 13C (figure F.4),
HSQC (figure F.5–F.6), HMBC (figure F.7–F.8) and COSY (figure
F.9) NMR spectra (appendix F).
Impurities in the spectra can be distinguished from the signals
belonging to 12 by HSQC correlations. Some of the additional peaks
may be due to isomers of 12. All 1H NMR signals < 1.35 ppm are
caused by impurities. Out of all the candidates for the 13C shift of
C-2, the signal with no protons attached is assigned (see figure F.5,
appendix F). Due to overlapping of 1H signals in the δ 6.70–6.50
ppm region, the stereochemistry of the C-4′=C-5′ bond cannot be
determined.
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Table 5.11: Assigned shifts for 12.
Carbon no. δ H (ppm) M J (Hz) δ C (ppm)
C-2 – – – 75.19
C-2a 1.44 s – 27.01
C-3 2.09–1.91 ma – 32.41
C-4 2.72–2.46 m – 21.04
C-4a – – – 117.4
C-5 – – – 118.5
C-5a 2.09 sa – 11.31
C-6 – – – 144.9
C-6–OH 4.23 s – –
C-7 – – – 121.1
C-7a 2.18 sa – 12.24
C-8 – – – 122.3
C-8a – – – 145.3
C-8b 2.21 sa – 11.85
C-1′ 9.44 s – 194.7
C-2′ – – – 136.9
C-2a′ 1.88 sa – 9.62
C-3′ 6.94–6.87 d 9.44 149.2
C-4′ 6.71–6.61 ma – 122.7
C-5′ 6.71–6.61 ma – 146.0
C-6′ – – – 134.6
C-6a′ 1.87 sa – 12.56
C-7′ 6.28–6.22 d 11.32 136.0
C-8′ 6.60–6.50 dd 15.12 124.811.32
C-9′ 5.97–5.90 d 15.12 141.6
aOverlapping with other signals
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5.6.2 MS fragmentation
The main fragments of 12 from LRMS by EI ionization (appendix F,
figure F.10) are shown in table 5.12. The naming of the fragments is
in accordance with figure 5.2.
Table 5.12: Main MS fragments of 12.
m/z Rel. intensity (%) Fragment Name
366 81 [M]+ –
229 15 [M−C9H13O]+ –
205 21 [M−C11H13O]+ B
203 25 [M−C11H15O]+ –
165 100 [M−C14H17O]+ C
121 16 [M−C16H21O2]+ –
105 16 [M−C16H21O3]+ –
91 23 [M−C17H23O3]+ –
Fragments B and C are also seen in the LRMS spectrum of 8
and 11, cf. figure 5.2. Fragment B is additionally seen in the LRMS
spectrum of 9. As for 11, the tropylium ion appears in the spectrum
at m/z 91. These fragments contribute to confirming the identity of
compound 12. The fragments may be formed either by direct frag-
mentation of the molecular ion or by subsequent fragmentation of a
fragment. Fragmentation may also be preceded by migrations and
rearrangements.
93
CHAPTER 5: Spectroscopy
Table 5.13: Main MS fragments of 9A.
m/z Rel. intensity (%) Fragment Name
338 8 [M]+ –
309 16 [M−CHO]+ K
234 19 [M−C7H4O]+ –
205 53 [M−C8H5O2]+ B
161 10 [M−C10H9O3]+ –
136 12 –
105 100 [M−C14H17O3]+ L
77 48 [M−C15H17O4]+ –
5.7 2-Formyl-2,5,7,8-tetramethylchroman-6-yl ben-
zoate (9A)
O
O
OO
9A
Figure 5.11: Structure of 9A.
Because no suitable solvent was found for 9A (figure 5.11) , NMR
analysis could not be performed. The identitification of 9A therefore
depends on MS spectrometry. The LRMS spectrum by EI ionization
of 9A (appendix G, figure G.1) is summarized in table 5.13. The
naming of the fragments is in accordance with figures 5.2 and 5.12.
Figure 5.12 shows the proposed structure of some of the fragments.
The loss of CHO (fragments B and K) is typical to aldehydes. Frag-
ment B is also seen in the LRMS spectra of 8 and 9, cf. figure 5.2.
The C6H+5 ion appears in the spectrum at m/z 77. These fragments
contribute to confirming the identity of compound 9A. The fragments
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O
BzO
K L
O
Figure 5.12: Possible radical ion fragments of 9A.
may be formed either by direct fragmentation of the molecular ion or
by subsequent fragmentation of a fragment. Fragmentation may also
be preceded by migrations and rearrangements.
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Experimental
6.1 General methods
6.1.1 Chemicals and solvents
Solvents and chemicals were supplied by Sigma-Aldrich, Merck, VWR,
Fluka Chemica and Fisher Scientific. The Wittig salts 10 and 13 were
generously donated by BASF.
Drying of solvents and reagents
Dry CH2Cl2, THF and DMF were obtained from a MBraun MB SPS-
800 Solvent Purification System and kept on activated molecular sieves
(4 Å) under N2 in pre-dried glassware. Other solvents and reagents
were dried with activated molecular sieves (4 Å).95
6.1.2 Chromatographic techniques
TLC was used for analytical monitoring of reaction progress (silica
60 on Al sheets, F254, 0.2 mm, Merck) and in some instances for
preparative purification of samples (silica 60 on glass plates, F254, 2.0
mm, Merck). Compounds with no UV absorption were developed with
phosphomolybdic acid (in ethanol, 20 wt%) and heat.
Flash column chromatography was performed on silica gel (60 Å,
230–400 mesh, Sigma-Aldrich Fluka). The eluent systems are specified
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for each compound.
6.1.3 Spectroscopic analyses
NMR spectroscopy
All samples were dissolved in CDCl3 containing tetramethylsilane
(TMS, 0.05% V/V) as internal reference. 1H and 13C NMR spec-
tra were recorded on a Bruker Advance DPX 400 MHz spectrometer
equipped with autosampler. The spectroscopic data was analyzed
with Bruker TopSpin 3.1. Shifts were assigned according to the fol-
lowing NMR experiments:
1D-NMR: 1H, 13C
2D-NMR: HSQC, HMBC, COSY
In the elucidation of the structure of compound 27, information from
the 1D-NMR experiment DEPT135 was also used. Shifts are assigned
in chapter 5. 1H signal splitting patterns are abbreviated s (singlet), d
(doublet), dd (doublet of doublets), ft (false triplet) and m (multiplet).
All spectra are found in appendixes A to F.
Mass spectrometry
Accurate mass determination was performed on a MAT95XL Ther-
moFinnigan (EI ionization mode) and Agilent G1969 TOF MS (ESI
ionization mode) instruments. For ESI analyses, samples were injected
into the instrument using an Agilent 1100 series HPLC instrument. A
direct injection analysis without any chromatography was performed
for the EI analyses.
UV/Vis spectroscopy
UV/Vis spectra were recorded on a Hitachi U-1900 J30-0003 single
beam spectrophotometer. Samples were dissolved in CH2Cl2 and con-
tained in a quartz cell.
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IR spectroscopy
All IR spectroscopy analyses were performed on neat samples on a
Thermo Nicolet 20SXF FT-IR single beam spectrophotometer with
a Smart Endurance reflection cell. Only the most characteristic IR
signals are reported, with signal intensities specified as s (strong), m
(medium) or br (broad).
6.2 Synthesis of 2-hydroxymethyl-2,5,7,8-tetra-
methylchroman-6-ol (8)
A solution of 7 (5.353 g, 21.4 mmol) in dry THF (145 mL) was placed
in a pre-dried two-neck flask under N2 and cooled to 0◦ C. Under stir-
ring, a solution of NaAlH2(OCH2CH2OCH3)2 in toluene (65% w/w,
32.5 mL, 108 mmol, 5.0 eq) was added dropwise over 20 min. The
solution was carefully warmed to room temperature and stirred for
1.5 h. The reaction mixture was carefully poured over a mixture of
HCl (6 M, 50 mL) and ice (50 mL). The aqueous phase was separated
from the organic phase and extracted with diethyl ether (3× 50 mL).
The combined organic phases were washed with HCl (2 M, 3 × 50
mL) and a solution of NaHCO3 (sat., 3 × 50 mL) before drying over
MgSO4. The solvent was removed and the product was obtained as
white crystals with no further purification necessary.80
Yield: 4.779 g, 20.22 mmol, 95%.
Rf: 0.65 (silica, hexane : acetone 6 : 4).
1H-NMR (CDCl3, 400 MHz): δ 4.29 (s, 1H, C-6–OH), 3.69–
3.55 (m, 2H, C-2b), 2.74–2.59 (m, 2H, C-4), 2.17 (s, 3H, C-7a),
2.12 (s, 3H, C-5a), 2.11 (s, 3H, C-8b), 2.05–1.90 (m, 2H, C-3 + C-
2b–OH), 1.77–1.69 (m, 1H, C-3), 1.22 (s, 3H, C-2a). 13C-NMR
(CDCl3 100 MHz): δ 145.2 (C-6), 145.0 (C-8a), 122.7 (C-8),
121.5 (C-7), 118.9 (C-5), 117.5 (C-4a), 75.20 (C-2), 69.51 (C-2b),
28.00 (C-3), 20.51 (C-2a), 20.38 (C-4), 12.31 (C-7a), 11.97 (C-8b),
11.42 (C-5a). LRMS (EI, 70 eV): [m/z (%)] 236 (94) [M]+, 218
(5) [M−H2O]+, 205 (90) [M−CH3O]+, 165 (100) [M−C4H7O]+,
164 (38) [M−C4H8O]+. HRMS (EI, 70 eV): m/z calcd. for
C14H20O3 [M]+ 236.1412, found 236.1415. IR (solid): cm−1
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3280br (O–H stretch), 1048s (C–O stretch).
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6.3 Attempted protection of 8
6.3.1 Attempted synthesis of (6-(tert-butyldimethylsilyl-
oxy)-2,5,7,8-tetramethylchroman-2-yl)methanol (8A)
A solution of TBDMS-Cl (1 M in THF, 1.1 mL, 1.1 mmol, 2.3 eq)
and imidazole (93 mg, 1.37 mmol, 3.2 eq) were dissolved in dry DMF
(0.5 mL) under N2 atmosphere. A solution of 8 (102 mg, 0.43 mmol)
was added under stirring. The reaction mixture was stirred while
the reaction progress was monitored by TLC. After 19 h all starting
material had been converted to a single product. The solvent was
removed, the residue dissolved in diethyl ether (5 mL) and washed
with HCl (1 M, 10 mL), aqueous NaHCO3 (sat., 10 mL) and water
(2 × 10 mL) and dried over MgSO4. After removal of the solvent, a
sample of the residue was purified by TCL (silica, 20% ethyl acetate
in hexane) for spectroscopic assessment. The product was isolated
as pale beige crystals.83 Spectroscopic data indicate that only the
primary hydroxy group was silylated (compound 8B). An attempt
was made to recover compound 8 directly from the crude product.
See section 6.3.2.
Rf: 0.76 (silica, hexane : ethyl acetate 8 : 2)
1H-NMR (CDCl3, 400 MHz): δ 4.19 (s, 1H, C-6–OH), 3.64–
3.58 (d, 1H, J = 9.76 Hz, C-2b), 3.54–3.48 (d, 1H, J = 9.76 Hz,
C2-b), 2.65–2.57 (t, 2H, J = 6.84, C-4), 2.16 (s, 3H, C-7a), 2.12 (s,
3H, C-5a), 2.11 (s, 3H, C-8b), 2.02–1.91 (m, 1H, C-3), 1.80–1.71
(m, 1H, C-3), 1.24 (s, 3H, C-2a), 0.91 (s, 9H, -Si-C-(CH3)3), 0.07
(s, 3H, -Si-CH3), 0.04 (s, 3H, -Si-CH3). 13C-NMR (CDCl3 100
MHz): δ 145.7 (C-6), 144.8 (C-8a), 122.6 (C-8), 121.2 (C-7), 118.6
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(C-5), 117.7 (C-4a), 75.31 (C-2), 68.57 (C-2b), 28.32 (C-3), 25.99
(-Si-C-(CH3)3), 22.18 (-Si-C-(CH3)3), 20.54 (C-4), 18.37 (C-2a),
12.35 (C-7a), 11.97 (C-8b), 11.44 (C-5a), −5.25 (-Si-CH3), −5.32
(-Si-CH3). HRMS (ESI, 70 eV): m/z calcd. for C20H35O3Si
[M + H]+ 351.2350, found 351.2344.
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6.3.2 Attempted recovery of 8 from 8B
The crude product (assuming 0.43 mmol) from the attempted synthe-
sis of 8A (see section 6.3.1) was dissolved in THF (3 mL) and cooled
to 0 ◦C. A solution of TBAF (1.0 M in THF, 0.63 mL, 0.63 mmol,
1.5 eq) was added dropwise under stirring. The reaction mixture was
stirred for 90 min at 0 ◦C, then warmed to room temperature and
stirred for 4 h. TLC monitoring showed the reaction mixture had
decomposed.85
6.3.3 Attempted synthesis of (6-benzyloxy-2,5,7,8-tetra-
methylchroman-2-yl)methanol (8C)
Benzyl chloride (80 µL, 0.63 mmol, 1.5 eq) was added to a solution
of 8 (100 mg, 0.42 mmol) in dry acetone (7 mL). K2CO3 (319 mg,
2.31 mmol, 5.5 eq), 18-crown-6 (1 mg, 1 mol%) and KI (trace) was
added to the reaction mixture. The mixture was refluxed under N2
with TLC monitoring of the reaction progress. After 96 h the reaction
mixture had decomposed without any apparent product formation.86
O
O
OH
8C
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6.4 Synthesis of 6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-carbaldehyde (9)
6.4.1 Attempted synthesis by the Dess-Martin oxidation
Method 1
Dess-Martin periodinane 25 (445 mg, 1.05 mmol, 2.5 eq) was added
to a solution of 8 (100 mg, 0.423 mmol) in dry CH2Cl2 (5 mL) under
stirring. A solution of H2O (19 µL, 1.05 mmol, 2.5 eq) in CH2Cl2 (3
mL) was added dropwise to the reaction mixture, followed by stirring
under N2 for 4 h 30 min. The reaction mixture was diluted with di-
ethyl ether (10 mL) and the solvent was removed. The residue was
dissolved in diethyl ether (15 mL) and washed with aqueous NaOH
(1 M, 20 mL), water (3 × 20 mL) and brine (20 mL) and dried over
Na2SO4. The solvent was removed and the product was obtained as
pale yellow crystals without further purification necessary.68,69 Spec-
troscopic data show that another product (27) than the desired one
was obtained.
Yield: 51 mg, 0.22 mmol, 52%
Rf: 0.61 (silica, hexane : ethyl acetate 8 : 2)
1H-NMR (CDCl3, 400 MHz): δ 4.18–4.14 (d, 1H, J = 6.88
Hz, C-2), 3.65–3.61 (d, 1H, J = 6.88 Hz, C-2), 2.74–2.53 (m, 2H,
C-5), 1.96–1.82 (2 × s + m, 8H, C-9b, C-8a, C-4), 1.79 (s, 3H,
C-6a), 1.42 (s, 3H, C-3a). 13C-NMR (CDCl3 100 MHz): δ
185.3 (C-7), 147.5 (C-5a), 145.4 (C-9), 134.5 (C-8), 126.8 (C-6),
100.1 (C-9a), 80.93 (C-3), 74.68 (C-2), 35.83 (C-4), 22.70 (C-5),
22.15 (C-3a), 12.91 (C-9b), 11.67 (C-8a), 10.41 (C-6a). LRMS
(EI, 70 eV): [m/z (%)] 234 (88) [M]+, 216 (12) [M−H2O]+, 206
(29) [M−CO]+, 204 (96) [M−CH2O]+, 189 (100) [M−C2H5O]+,
161 (46) [M−C3H5O2]+. HRMS (ESI, 70 eV): m/z calcd. for
C14H19O3 [M + H]+ 235.1329, found 235.1324. IR (solid): cm−1
1629s (C=O stretch), 941s (C–O stretch).
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Method 2
Dess-Martin periodinane 25 (270 mg, 0.637 mmol, 1.5 eq) was added
to a solution of 8 (100 mg, 0.423 mmol) in water saturated CH2Cl2 (5
mL) under stirring. The solution was stirred vigorously under N2 for
1 h 40 min while reaction progress was monitored by TLC. When the
reaction was complete, the reaction mixture was diluted with diethyl
ether (10 mL) and the solvent was removed. The residue was dissolved
in diethyl ether (15 mL) and treated with a 1:1 mixture (in total 15
mL) of aqueous Na2S2O3 (10%) and aqueous NaHCO3 (sat.). The
organic phase was washed with H2O (10 mL) and brine (10 mL).
The combined aqueous washings were extracted with diethyl ether
(2 × 20 mL). The combined organic phases were washed with H2O
(2 × 20 mL) and brine (20 mL) and dried over Na2SO4. The solvent
was removed and the product was obtained as pale yellow crystals
without further purification necessary.68,69 Spectroscopic data show
that another product (27) than the desired one was obtained.
Yield: 71 mg, 0.30 mmol, 71%
Spectroscopic data were identical to the product from method 1.
6.4.2 Synthesis by the Swern oxidation
A solution of oxalyl chloride (0.45 mL, 5.3 mmol, 1.25 eq) in dry
CH2Cl2 (30 mL) was cooled and maintained under −75 ◦C on a dry
ice/diethyl ether cooling bath under N2 flow. Under stirring, a solu-
tion of dry DMSO (0.75 mL, 10.6 mmol, 2.51 eq) in dry CH2Cl2 (20
mL) was added carefully over 15 min. After stirring for 15 min, a
solution of 8 (1000 mg, 4.23 mmol) in dry CH2Cl2 (40 mL) was added
over 10 min. The reaction mixture was stirred for 45 min. Triethy-
lamine (3.0 mL, 21.5 mmol, 5.08 eq) in dry CH2Cl2 (8 mL) was added
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over 5 min with careful monitoring of the temperature. The reaction
mixture was stirred for 5 min, before warming to room temperature.
H2O (50 mL) was added to the reaction mixture. The phases were
separated and the aqueous layer was extracted with CH2Cl2 (3 × 50
mL). The combined organic phases were washed with HCl (1%, 3×50
mL), water (3× 50 mL), Na2CO3 (5%, 3× 50 mL) and brine (5× 50
mL) and dried over MgSO4. The solvent was evaporated in vacuo
and the crude product was purified by flash column chromatography
(silica, 2% ethyl acetate in CH2Cl2). The product was obtained as
white crystals.21,80
Yield: 645 mg, 2.75 mmol, 65%
Rf: 0.55 (silica, hexane : ethyl acetate 8 : 2)
1H-NMR (CDCl3, 400 MHz): δ 9.61 (s, 1H, C-2b), 4.30 (s,
1H, C-6–OH), 2.67–2.48 (m, 2H, C-4), 2.31–2.22 (m, 1H, C-3),
2.20 (s, 3H, C-8b), 2.17 (s, 3H, C-7a), 2.06 (s, 3H, C-5a), 1.86–
1.76 (m, 1H, C-3), 1.38 (s, 3H, C-2a). 13C-NMR (CDCl3 100
MHz): δ 204.7 (C-2b), 145.7 (C-6), 145.3 (C-8a), 122.9 (C-8),
121.7 (C-7), 118.8 (C-5), 117.6 (C-4a), 80.41 (C-2), 28.05 (C-3),
21.66 (C-2a), 20.51 (C-4), 12.32 (C-7a), 12.00 (C-8b), 11.34 (C-
5a). LRMS (EI, 70 eV): [m/z (%)] 234 (31) [M]+, 205 (100)
[M−CHO]+, 190 (22) [M−C2H4O]+. HRMS (EI, 70 eV): m/z
calcd. for C14H18O3 [M]+ 236.1250, found 234.1247. IR (solid):
cm−1 3535br (O–H stretch), 1732s (C=O stretch), 1085s (C–O
stretch).
O
HO
O2
2a
2b
3
4
4a
5
5a
6
7a
7
8
8b
8a
9
103
CHAPTER 6: Experimental
6.5 Synthesis of 5-(6-hydroxy-2,5,7,8-tetra-
methylchroman-2-yl)-2-methylpenta-2,4-di-
enal (11)
6.5.1 Method 1: Epoxide mediation under microwave con-
ditions
A solution of 9 (20 mg, 0.085 mmol) in absolute ethanol (2 mL) was
added slowly by syringe to a suspension of 10 (220 mg, 0.431 mmol, 5.1
eq) in 1,2-epoxybutane (5 mL) in a pre-dried glass vial at 0 ◦ C under
stirring. The cooling bath was removed and the reaction mixture was
stirred for 30 min at room temperature. After equipping the vial with
a screwcap, the reaction mixture was irradiated by MW radiation
(320 W) for in total 1 h 10 min, with regular intermediate monitoring
of reaction progress by TLC. Due to beginning decomposition the
reaction was stopped, even though starting material was still present
in the reaction mixture. H2O (5 mL) was carefully added and the
mixture was stirred for 10 min. The solvent was removed and the
residue was dissolved in CH2Cl2 (10 mL) and washed with H2O (3×10
mL). After drying over MgSO4 the solvent was removed. The residue
was dissolved in dry CH2Cl2 (10 mL), a few crystals of p-TsOH was
added and the mixture was stirred under N2 for 30 min until TLC
monitoring showed the reaction was complete. The reaction mixture
was transferred to a separatory funnel and washed with a solution
of NaHCO3 (5%, 3 × 10 mL), H2O (3 × 10 mL) and brine (10 mL).
After drying over MgSO4 the solvent was removed. A sample of the
crude product was saved for TLC evaluation and comparison with
other methods.
6.5.2 Method 2: Epoxide mediation under reflux
A solution of 9 (20 mg, 0.085 mmol) in absolute ethanol (1.5 mL) was
added slowly by syringe under N2 to a suspension of 10 (230 mg, 0.451
mmol, 5.3 eq) in 1,2-epoxybutane (5 mL) at 0 ◦ C under stirring. The
cooling bath was removed and the reaction mixture was stirred for 30
min at room temperature. The reaction mixture was refluxed while
reaction progress was monitored by TLC. After 72 h the reaction
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was stopped due to beginning decomposition, even though starting
material was still present in the reaction mixture. H2O (5 mL) was
carefully added and the mixture was stirred for 10 min. The solvent
was removed and the residue was dissolved in CH2Cl2 (10 mL) and
washed with H2O (3× 10 mL). After drying over MgSO4 the solvent
was removed. The residue was dissolved in dry CH2Cl2 (10 mL), a few
crystals of p-TsOH was added and the mixture was stirred under N2 for
30 min until TLC monitoring showed the reaction was complete. The
reaction mixture was transferred to a separatory funnel and washed
with a solution of NaHCO3 (5%, 3 × 10 mL), H2O (3 × 10 mL) and
brine (10 mL). After drying over MgSO4 the solvent was removed.
A sample of the crude product was saved for TLC evaluation and
comparison with other methods.
6.5.3 Method 3: Base mediation under microwave
conditions
To a solution of 10 (3.285 g, 6.424 mmol, 3.0 eq) in dry methanol (15
mL), CH3OK (25% in methanol, 1.9 mL, 6.4 mmol, 3.0 eq) in dry
methanol (3 mL) was added dropwise at 0 ◦ C under stirring. The
solution was stirred on ice cooling for 15 min before a solution of 9
(504 mg, 2.15 mmol) in dry CH2Cl2 (5 mL) was added slowly. The
reaction mixture was warmed to room temperature and stirred for 15
min, before being submitted to irradiation by MW radiation (90 W)
for 26 min. The reaction was quenched with H2O (5 mL) and the
mixture was concentrated in vacuo. CH2Cl2 (30 mL) was added, the
mixture was washed with H2O (5 × 30 mL) and dried over MgSO4.
The solvent was removed and the residue dissolved in dry CH2Cl2
(15 mL). p-TsOH (215 mg, 1.13 mmol, 0.53 eq) was added and the
reaction mixture stirred under N2 for 45 min until TLC monitoring
showed the reaction was complete. The mixture was transferred to a
separatory funnel and washed with a solution of NaHCO3 (5%, 3×50
mL) and H2O (3× 50 mL). The organic phase was dried over MgSO4
and the solvent was removed. The crude product was dissolved in
CH2Cl2 and filtered through silica before purification by flash column
chromatography (silica, (2 : 1 CH2Cl2 : ethyl acetate)/hexane gradi-
ent).
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Yield: 125 mg, 0.416 mmol, 19% (37 : 63 cis : trans)
Rf: 0.53 (cis), 0.46 (trans) (silica, hexane : ethyl acetate 7 : 3)
Spectroscopic data were identical to the products from method 4.
6.5.4 Method 4: Base mediation under reflux
To a solution of 10 (4.375 g, 8.555 mmol, 5.15 eq) in dry methanol (25
mL), CH3ONa (25% in methanol, 2.0 mL, 8.7 mmol, 5.2 eq) in dry
methanol (4 mL) was added dropwise at 0 ◦ C under stirring and N2.
The solution was stirred on ice cooling for 20 min before a solution
of 9 (389 mg, 1.66 mmol) in dry THF (4 mL) was added slowly. The
reaction mixture was warmed to room temperature and stirred for 30
min, before being refluxed for 22 h. The reaction was quenched with
H2O (5 mL) and the mixture was concentrated in vacuo. CH2Cl2 (40
mL) was added, the mixture was washed with H2O (3× 30 mL) and
dried over MgSO4. The solvent was removed and the residue dissolved
in dry CH2Cl2 (25 mL). One spatula measure p-TsOH was added and
the reaction mixture stirred under N2 for 60 min until TLC monitoring
showed the reaction was complete. The mixture was transferred to a
separatory funnel and washed with a solution of NaHCO3 (5%, 3×50
mL) and H2O (3× 50 mL). The organic phase was dried over MgSO4
and the solvent was removed. The crude product was purified by flash
column chromatography (silica, (2 : 1 CH2Cl2 : ethyl acetate)/hexane
gradient).
Yield: 131 mg, 0.44 mmol, 26% (72 : 28 cis : trans)
Rf: 0.53 (cis), 0.46 (trans) (silica, hexane : ethyl acetate 7 : 3)
cis-Isomer: 1H-NMR (CDCl3, 400 MHz): δ 9.45 (s, 1H,
C-1′), 7.82–7.72 (d, 1H, J = 11.96 Hz, C-3′), 6.49–6.38 (dd, 1H,
J = 11.96, 11.80, C-4′), 5.91–5.82 (d, 1H, J = 11.80, C-5′), 4.32
(s, 1H, C-6–OH), 2.74–2.55 (m, 2H, C-4), 2.20 (s, 3H, C-8b), 2.15
(s, 3H, C-7a), 2.10 (s, 3H, C-5a), 2.15–2.01 (m, 1H, C-3), 1.90–
1.79 (m, 1H, C-3), 1.77 (s, 3H, C-2a′), 1.56 (s, 3H, C-2a). 13C-
NMR (CDCl3 100 MHz): δ 195.7 (C-1′), 145.5 (C-6), 145.2
(C-8a), 144.4 (C-3′), 143.6 (C-5′), 139.1 (C-2′), 124.8 (C-4′), 122.4
(C-8), 121.8 (C-7), 119.1 (C-5), 117.7 (C-4a), 76.77 (C-2), 33.91
(C-3), 27.79 (C-2a), 21.35 (C-4), 12.62 (C-8b), 12.57 (C-7a), 11.66
(C-5a), 9.13 (C-2a′). LRMS (EI, 70 eV): [m/z (%)] 300 (61)
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[M]+, 205 (27) [M−C6H7O]+, 165 (100) [M−C9H11O]+, 164 (67)
[M−C9H12O]+. HRMS (ESI, 70 eV): m/z calcd. for C19H25O3
[M + H]+ 301.1798, found 301.1797. IR (neat): cm−1 3450br
(O–H stretch), 1667s (C=O stretch), 1630s (C=C stretch), 1084s
(C–O stretch). UV/Vis (CH2Cl2): λmax 275 nm.
trans-Isomer: 1H-NMR (CDCl3, 400 MHz): δ 9.39 (s, 1H,
C-1′), 6.83–6.76 (d, 1H, J = 11.28 Hz, C-3′), 6.67–6.58 (dd, 1H,
J = 15.12, 11.28, C-4′), 6.28–6.20 (d, 1H, J = 15.12, C-5′), 4.50 (s,
1H, C-6–OH), 2.71–2.43 (m, 2H, C-4), 2.20 (s, 3H, C-8b), 2.17 (s,
3H, C-7a), 2.09 (s, 3H, C-5a), 2.05–1.84 (m, 2H, C-3), 1.75 (s, 3H,
C-2a′), 1.45 (s, 3H, C-2a). 13C-NMR (CDCl3 100 MHz): δ
195.4 (C-1′), 148.5 (C-3′), 147.8 (C-5′), 145.4 (C-6), 145.4 (C-8a),
137.8 (C-2′), 124.1 (C-4′), 122.5 (C-8), 121.7 (C-7), 119.0 (C-5),
117.5 (C-4a), 75.45 (C-2), 32.47 (C-3), 27.00 (C-2a), 21.26 (C-4),
12.55 (C-7a), 12.11 (C-8b), 11.62 (C-5a), 9.73 (C-2a′). UV/Vis
(CH2Cl2): λmax 275 nm.
6.5.5 Alternative method of hydrolyzing the acetal precur-
sor to 11
The crude intermediate after MW irradiation and washing with H2O
according to method 3 (section 6.5.3) was dissolved in a solution of
citric acid in dry methanol (30%) and refluxed for 26 h until TLC
monitoring showed the reaction was complete. Workup of the product
was performed according to method 3 (section 6.5.3).
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6.6 Synthesis of 9-(6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-yl)-2,6-dimethylnona-2,4,6,8-tetra-
enal (12)
In a pre-dried glass vial with septum and N2 flow, a solution of 10 (639
mg, 1.25 mmol, 3.0 eq) in dry methanol (1 mL) was cooled to −10 ◦ C.
A solution of CH3OK (25% in methanol, 365 µL, 1.24 mmol, 3.0 eq) in
dry methanol (1 mL) was added dropwise over 10 min. The mixture
was stirred at −10 ◦ C for 20 min before 11 (125 mg, 0.416 mmol) in
dry CH2Cl2 (1.5 mL) was added over 10 min. The reaction mixture
was stirred for 5 min, then warmed to room temperature and stirred
for an additional 30 min. After equipping the vial with a screwcap,
the reaction mixture was irradiated by MW radiation (80 W) for 25
min. H2O (1 mL) was added and the mixture was stirred for 10 min.
The solvent was removed and the residue was dissolved in CH2Cl2 (10
mL) and washed with H2O (3×25 mL). After drying over MgSO4 the
solvent was removed. The residue was dissolved in dry CH2Cl2 (10
mL), p-TsOH (150 mg, 0.794 mmol, 1.9 eq) was added and the mixture
was stirred under N2 for 30 min. The reaction mixture was transferred
to a separatory funnel and washed with a solution of NaHCO3 (5%,
3 × 25 mL), H2O (3 × 25 mL) and brine (25 mL). After drying over
MgSO4 the solvent was removed. The crude product was purified
by flash column chromatography (silica, ethyl acetate/cyclohexane
gradient).
Yield: 11 mg, 0.030 mmol, 7%
Rf: 0.62 (silica, hexane : ethyl acetate 7 : 3)
1H-NMR (CDCl3, 400 MHz): δ 9.44 (s, 1H, C-1′), 6.94–6.87
(d, 1H, J = 9.44 Hz, C-3′), 6.71–6.61 (m, 2H, C-4′ + C-5′), 6.60–
6.50 (dd, 1H, J = 15.12, 11.32 Hz, C-8′), 6.28–6.22 (d, 1H, J =
11.32 Hz, C-7′), 5.97–5.90 (d, 1H, J = 15.12, C-9′), 4.23 (s, 1H,
C-6–OH), 2.72–2.46 (m, 2H, C-4), 2.21 (s, 3H, C-8b), 2.18 (s,
3H, C-7a), 2.09 (s, 3H, C-5a), 2.09–1.91 (m, 2H, C-3), 1.88 (s,
3H, C-2a′), 1.87 (s, 3H, C-6a′), 1.44 (s, 3H, C-2a). 13C-NMR
(CDCl3 100 MHz): δ 194.7 (C-1′), 149.2 (C-3′), 146.0 (C-5′),
145.3 (C-8a), 144.9 (C-6), 141.6 (C-9′), 136.9 (C-2′), 136.0 (C-7′),
134.6 (C-6′), 124.8 (C-8′), 122.7 (C-4′), 122.3 (C-8), 121.1 (C-7),
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118.5 (C-5), 117.4 (C-4a), 75.19 (C-2), 32.41 (C-3), 27.01 (C-2a),
21.04 (C-4), 12.24 (C-7a), 11.85 (C-8b), 11.31 (C-5a), 12.56 (C-
6a′), 9.62 (C-2a′). LRMS (EI, 70 eV): [m/z (%)] 366 (81) [M]+,
205 (21) [M−C11H13O]+, 165 (100) [M−C14H17O]+. HRMS (EI,
70 eV): m/z calcd. for C24H30O3 [M]+ 366.2189, found 366.2186.
IR (neat): cm−1 3437br (O–H stretch), 1668s (C=O stretch),
1579s (C=C stretch), 1191s (C–O stretch). UV/Vis (CH2Cl2):
λmax 350 nm.
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6.7 Attempted protection of 9
6.7.1 Synthesis of 2-formyl-2,5,7,8-tetramethyl-
chroman-6-yl benzoate (9A)
Method 1
9 (145 mg, 0.619 mmol) was dissolved in dry CH2Cl2 (2 mL) under
N2 atmosphere. A solution of dry pyridine (60 µL, 0.74 mmol, 1.2 eq)
in dry CH2Cl2 (1 mL) was added slowly under stirring on ice cooling.
After stirring for 30 min on ice cooling, a solution of benzoyl chloride
(90 µL, 0.77 mmol, 1.2 eq) in dry CH2Cl2 (1 mL) was added slowly.
After stirring for 10 min, the reaction mixture was allowed to warm to
room temperature and stirred for 22 h.25 TLC monitoring showed no
reaction had taken place. DMAP (78 mg, 1 eq) was added78 and the
reaction mixture was stirred for an additional 68 h. As TLC monitor-
ing still indicated no product was formed, DCC (143 mg, 0.693 mmol,
1.1 eq) in dry CH2Cl2 (1 mL) was added to the reaction mixture.93
After an additional 24 h of stirring, H2O (10 mL) was added and the
reaction mixture stirred for 30 min. The phases were separated and
the organic phase washed with HCl (1%, 3×25 mL), H2O (3×25 mL),
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a solution of NaHCO3 (sat., 3 × 25 mL) and brine (3 × 25 mL). The
organic phase was dried over MgSO4 and the solvent was removed.
The white crystals formed were insoluble in all common laboratory
solvents.
Method 2
9 (114 mg, 0.487 mmol) was dissolved in dry pyridine (2 mL) under
N2 atmosphere. Under stirring, benzoyl chloride (100 µL, 0.86 mmol,
1.77 eq) was added dropwise. The reaction mixture was stirred for 15
min until TLC monitoring showed no starting material remained. The
reaction mixture was diluted with CH2Cl2 (100 mL) and the resulting
suspension was washed with a solution of NaHCO3 (sat., 3×100 mL),
HCl (2 M, 4 × 50 mL) and brine (3 × 100 mL). The organic phase
was dried over MgSO4. After removal of the solvent, no residue was
formed. The combined aqueous phases were acidified to suspend the
solid material in the organic phase, and extracted with CH2Cl2 (3×50
mL). The combined organic phases were washed with brine (1 × 50
mL) and the solvent was removed. The crude product (pale yellow
crystals) was very poorly soluble in all common laboratory solvents.
A small sample of the crude product was found by MS to contain the
desired product (9A).
Yield: 143 mg, 0.423 mmol, 87% (crude)
HRMS (ESI, 70 eV): m/z calcd. for C21H22O4 [M]+ 338.1513,
found 338.1512.
O
O
OO
9A
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6.7.2 Attempted synthesis of 6-(tert-butyldimethylsilyl-
oxy)-2,5,7,8-tetramethylchroman-2-carbaldehyde (9B)
A solution of 9 (100 mg, 0.427 mmol), TBDMS-Cl (1 M in THF, 0.64
mL, 0.64 mmol, 1.5 eq) and imidazole (116 mg, 1.71 mmol, 4 eq) in
dry DMF (4 mL) was stirred at 90 ◦C for 5 h under N2 atmosphere.
As TLC analysis showed no product had been formed, the reaction
mixture was refluxed overnight. The following morning, the reaction
had decomposed with no apparent product formation.96
O
O
O
9B
Si
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Figure A.1: IR spectrum of 8.
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Figure A.2: 1H NMR spectrum of 8.
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Figure A.3: 13C NMR spectrum of 8.
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Figure A.4: HSQC NMR spectrum of 8.
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Figure A.5: HMBC NMR spectrum of 8.
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Figure A.6: Enlargement of HMBC NMR spectrum of 8.
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Figure A.7: COSY NMR spectrum of 8.
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Figure A.8: LRMS spectrum with EI ionization of 8.
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Figure B.1: 1H NMR spectrum of 8B.
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Figure B.2: 13C NMR spectrum of 8B.
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Figure C.1: IR spectrum of 27.
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Figure C.2: 1H NMR spectrum of 27.
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Figure C.3: 13C NMR spectrum of 27.
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Figure C.4: DEPT135 NMR spectrum of 27.
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Figure C.5: HSQC NMR spectrum of 27.
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Figure C.6: HMBC NMR spectrum of 27.
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Figure C.7: Enlargements of the HMBC NMR spectrum of 27.
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Figure C.8: COSY NMR spectrum of 27.
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Figure C.9: LRMS spectrum with EI ionization of 27.
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Figure D.1: IR spectrum of 9.
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Figure D.2: 1H NMR spectrum of 9.
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Figure D.3: 13C NMR spectrum of 9.
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Figure D.4: HSQC NMR spectrum of 9.
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Figure D.5: HMBC NMR spectrum of 9.
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Figure D.6: Enlargements of the HMBC NMR spectrum of 9.
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Figure D.7: COSY NMR spectrum of 9.
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Figure D.8: LRMS spectrum with EI ionization of 9.
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Figure E.1: IR spectrum of 11.
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Figure E.2: UV/Vis spectra of (4Z )-11 (top) and (4E)-11 (bottom).
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Figure E.3: 1H NMR spectrum of (4Z )-11.
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Figure E.4: 13C NMR spectrum of (4Z )-11.
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Figure E.5: HSQC NMR spectrum of (4Z )-11.
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E. Spectroscopic data of 11
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Figure E.6: Enlargements of the HSQC NMR spectrum of (4Z )-11.
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Figure E.7: HMBC NMR spectrum of (4Z )-11.
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Figure E.8: Enlargements of the HMBC NMR spectrum of (4Z )-11.
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Figure E.8: Enlargements of the HMBC NMR spectrum of (4Z )-11 (cont.).
156
E. Spectroscopic data of 11
pp
m
10
9
8
7
6
5
4
3
2
1
0
pp
m
109876543210
Figure E.9: COSY NMR spectrum of (4Z )-11.
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Figure E.10: 1H NMR spectrum of (4E)-11.
158
E. Spectroscopic data of 11
20
0
19
0
18
0
17
0
16
0
15
0
14
0
13
0
12
0
11
0
10
0
90
80
70
60
50
40
30
20
10
pp
m
9.73
11.62
12.11
12.55
21.26
27.00
32.47
75.45
77.04
77.36
77.68
117.45
119.02
121.75
122.52
124.15
137.83
145.38
145.41
147.81
148.53
195.39
14
5
p
p
m
10
p
p
m
Figure E.11: 13C NMR spectrum of (4E)-11.
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Figure E.12: HSQC NMR spectrum of (4E)-11.
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Figure E.13: Enlargements of the HSQC NMR spectrum of (4E)-11.
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Figure E.14: HMBC NMR spectrum of (4E)-11.
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Figure E.15: Enlargements of the HMBC NMR spectrum of (4E)-11.
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Figure E.15: Enlargements of the HMBC NMR spectrum of (4E)-11
(cont).
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Figure E.16: COSY NMR spectrum of (4E)-11.
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Figure E.17: LRMS spectrum with EI ionization of 11.
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Figure F.1: IR spectrum of 12.
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Figure F.2: UV/Vis spectrum of 12.
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F. Spectroscopic data of 12
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Figure F.3: 1H NMR spectrum of 12.
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Figure F.4: 13C NMR spectrum of 12.
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F. Spectroscopic data of 12
pp
m
10
9
8
7
6
5
4
3
2
1
0
pp
m
14
0
12
0
10
0806040200
Figure F.5: HSQC NMR spectrum of 12.
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Figure F.6: Enlargements of the HSQC NMR spectrum of 12.
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F. Spectroscopic data of 12
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Figure F.7: HMBC NMR spectrum of 12.
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Figure F.8: Enlargements of the HMBC NMR spectrum of 12.
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F. Spectroscopic data of 12
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Figure F.8: Enlargements of the HMBC NMR spectrum of 12 (cont.).
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Figure F.9: COSY NMR spectrum of 12.
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F. Spectroscopic data of 12
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Figure F.10: LRMS spectrum with EI ionization of 12.
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G Spectroscopic data of 9A
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Figure G.1: LRMS spectrum with EI ionization of 9A.
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